Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Ribosome,-0.7478436791737262,-2.692970965612772,0.0,0.0,0.0,97/127,19.28%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL24;RPL5;RPL27A;RPL23;RPL13;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPS3A1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPS18;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;MRPS5;RPL17;UBA52;RPL30;MRPL21;RPL7A;RPS5;RPS2;RPS13;MRPL23;RPL7;MRPS12;MRPL20;RPL10;RPS12;RPL36A;RPS16;MRPL35;MRPL18;MRPL36;RPS26;RPL35;RPS6;RPL9;MRPL4;MRPL15;RPL31;MRPS10;RPL22L1;MRPL28;MRPL19;RPS15A;MRPL27;MRPS7;MRPL11;RPL14;MRPL33;MRPL14;RPL32;RPS9;MRPS16;MRPS17
gsea,Parkinson disease,-0.6873565606852079,-2.6584701824830863,0.0,0.0,0.0,69/113,17.54%,UBB;NDUFA4;SLC25A4;SLC25A5;ATP5G1;ATP5B;COX6C;COX8A;COX7C;SNCA;NDUFC1;UQCRQ;COX4I1;ATP5E;NDUFB3;NDUFA1;CYC1;VDAC1;ATP5C1;UQCR10;COX7A2;ATP5J;NDUFA13;ATP5G2;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;UQCRC1;NDUFB11;VDAC3;ATP5H;NDUFB9;COX6A1;ATP5G3;COX7A2L;COX6B1;NDUFA7;NDUFC2;NDUFAB1;UQCRB;NDUFB8;PARK7;NDUFS7;VDAC2;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;ATP5O;NDUFB5;NDUFA6;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;ATP5D;UQCRH;NDUFB4
gsea,Non-alcoholic fatty liver disease (NAFLD),-0.6014915913050676,-2.618446817560766,0.0,0.0,0.0,65/124,17.54%,NDUFA4;COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;NDUFB3;NDUFA1;CYC1;GSK3B;UQCR10;JUN;COX7A2;NDUFA13;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;UQCRC1;NDUFB11;NDUFB9;CDC42;TGFB1;COX6A1;COX7A2L;COX6B1;NDUFA7;NDUFC2;NDUFAB1;RAC1;TNFRSF1A;UQCRB;NDUFB8;AKT3;IRS2;NDUFS7;XBP1;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;ATF4;AKT1;NDUFB5;NDUFA6;CASP8;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;RELA;PPARA;COX5A;UQCRH;NDUFB4
gsea,Oxidative phosphorylation,-0.695146116592592,-2.6047921939978296,0.0,0.0,0.0,73/105,17.97%,ATP6V0B;ATP5K;NDUFA4;ATP6V1G2;ATP5G1;ATP6V0C;ATP5B;COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;ATP5E;NDUFB3;NDUFA1;CYC1;ATP5C1;COX17;UQCR10;COX7A2;ATP5J;NDUFA13;ATP6V1F;ATP5G2;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;ATP6V0E2;NDUFB2;COX5B;UQCR11;NDUFS8;COX11;UQCRC1;NDUFB11;ATP5H;NDUFB9;ATP6V1A;COX6A1;ATP5G3;ATP5L;COX7A2L;COX6B1;NDUFA7;NDUFC2;NDUFAB1;UQCRB;NDUFB8;NDUFS7;NDUFA5;NDUFA8;NDUFS6;NDUFV3;ATP5J2;NDUFV1;NDUFA11;ATP5O;NDUFB5;NDUFA6;ATP6V1G1;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;ATP5D;UQCRH;NDUFB4;ATP6V1D
gsea,Alzheimer disease,-0.6004296810370927,-2.5886147470895473,0.0,0.0,0.0,76/147,17.54%,CALM1;CALM2;NDUFA4;CALM3;ATP5G1;ATP5B;COX6C;COX8A;COX7C;SNCA;NDUFC1;UQCRQ;COX4I1;ATP5E;NDUFB3;GAPDH;NDUFA1;CYC1;GSK3B;ATP5C1;APOE;UQCR10;COX7A2;ATP5J;NDUFA13;ATP5G2;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;UQCRC1;NDUFB11;ATP5H;NDUFB9;COX6A1;ATP5G3;COX7A2L;COX6B1;PPP3R1;NDUFA7;NDUFC2;NDUFAB1;PPP3CA;TNFRSF1A;UQCRB;NDUFB8;NDUFS7;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;ATP5O;PLCB1;NDUFB5;NDUFA6;CASP8;NDUFA12;NDUFA2;ATF6;NDUFA10;CACNA1F;NDUFS1;FADD;SDHB;COX5A;ATP5D;UQCRH;NDUFB4
gsea,Thermogenesis,-0.5539967349535111,-2.563611162326083,0.0,0.0,0.0,87/195,17.54%,ATP5K;NDUFA4;ACTB;ATP5G1;ATP5B;COX6C;COX8A;COX7C;HRAS;NDUFC1;UQCRQ;COX4I1;ATP5E;NDUFB3;NDUFA1;COX19;CPT1C;CYC1;ATP5C1;COX17;UQCR10;COX7A2;ATP5J;ACTG1;NDUFA13;KRAS;MLST8;ATP5G2;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;NDUFAF4;COX11;UQCRC1;NDUFB11;ATP5H;NDUFB9;NDUFAF7;COX6A1;ATP5G3;ATP5L;COX7A2L;COX6B1;NDUFA7;NDUFC2;NDUFAF1;COX14;NDUFAB1;ACSL3;UQCRB;RHEB;NDUFB8;NDUFS7;COX20;RPS6KB2;NDUFA5;NDUFA8;NDUFS6;NDUFV3;ATP5J2;NDUFV1;NDUFA11;COA6;ATP5O;ATF2;GNAS;RPS6;NDUFB5;NDUFA6;COA5;PRKG1;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;ATP5D;COA3;UQCRH;NDUFB4
gsea,Huntington disease,-0.5474669807520048,-2.4368531954474455,0.0,0.0,0.0,80/168,17.54%,NDUFA4;SLC25A4;SLC25A5;ATP5G1;ATP5B;COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;ATP5E;NDUFB3;NDUFA1;CYC1;VDAC1;ATP5C1;UQCR10;COX7A2;ATP5J;NDUFA13;ATP5G2;UQCRFS1;COX7B;NDUFS5;CLTB;CLTA;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;UQCRC1;NDUFB11;VDAC3;ATP5H;NDUFB9;COX6A1;ATP5G3;COX7A2L;COX6B1;NDUFA7;NDUFC2;NDUFAB1;BDNF;UQCRB;NDUFB8;DCTN1;NDUFS7;DNAH3;VDAC2;NDUFA5;POLR2G;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;ATP5O;AP2M1;PLCB1;POLR2F;NDUFB5;DNAH1;NDUFA6;SOD1;CASP8;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;DCTN4;COX5A;GPX1;ATP5D;UQCRH;NDUFB4
gsea,Cardiac muscle contraction,-0.5712651473457288,-2.277230598021604,0.0,0.0,0.0,27/61,17.84%,ATP1B1;COX6C;COX8A;COX7C;UQCRQ;COX4I1;CYC1;UQCR10;COX7A2;UQCRFS1;COX7B;COX5B;UQCR11;UQCRC1;COX6A1;COX7A2L;COX6B1;UQCRB;ATP1A2;ATP1B2;TPM1;ATP1A1;CACNB3;CACNA1F;COX5A;UQCRH;ATP1B3
gsea,Protein export,-0.6286030421162091,-2.0807241451594813,0.0,0.0023363886107473876,0.01,15/27,14.72%,SEC62;IMMP2L;SEC61G;SRPR;SPCS2;SRP9;SRPRB;HSPA5;IMMP1L;ARXES2;SEC11C;SEC61B;OXA1L;SEC63;ARXES1
gsea,Ferroptosis,-0.5718383120228882,-2.0699165820477954,0.0,0.002102749749672649,0.01,16/36,23.78%,FTH1;FTL1;PRNP;VDAC3;MAP1LC3B;GSS;ACSL3;SAT1;VDAC2;TRF;SLC3A2;TFRC;SLC40A1;PCBP1;STEAP3;GPX4
gsea,Mineral absorption,-0.5917234961843785,-2.035640511239214,0.0,0.003087954177840953,0.017,15/30,19.49%,FTH1;ATP1B1;MT1;FTL1;ATP1A2;ATP1B2;HMOX2;TRF;ATP1A1;ATOX1;SLC9A3;ATP1B3;SLC40A1;ATP2B1;CLCN2
gsea,Proteasome,-0.5619589461683044,-2.0335625541497415,0.001941747572815534,0.003100207964260957,0.019,20/40,19.29%,PSMA3;PSMD7;PSMB3;PSMC6;PSMC1;POMP;PSMB6;PSMC3;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Cholesterol metabolism,-0.5657772565939039,-2.0090167709277917,0.0,0.0034838457391026135,0.023,10/33,9.66%,VDAC1;APOE;LRPAP1;PLTP;VDAC3;APOA1;STAR;NCEH1;LDLR;VDAC2
gsea,Necroptosis,-0.4416980034975691,-1.9688693815391092,0.0,0.00519910652391589,0.036,28/99,15.94%,FTH1;SLC25A4;HMGB1;SLC25A5;PPIA;HSP90AB1;VDAC1;FTL1;VDAC3;IFNGR2;SPATA2;TNFRSF1A;FAF1;SPATA2L;CHMP2A;CHMP5;HSP90AA1;VDAC2;CHMP4B;SQSTM1;GLUL;TYK2;PPID;PARP3;CASP8;TLR3;BCL2;FADD
gsea,Pertussis,-0.5145942850333469,-1.9608746076315453,0.0022675736961451248,0.0056073326657937305,0.042,22/46,25.09%,CALM1;CALM2;CALM3;CFL1;JUN;C1QB;TRAF6;CFL2;RHOA;C2;RELA;FOS;C1QC;MAPK3;IRF1;PYCARD;LY96;SERPING1;ITGAM;TLR4;ITGB1;C1QA
gsea,Glutathione metabolism,-0.5190836922831013,-1.9561568328459205,0.0,0.005661249326041747,0.046,21/41,30.33%,ODC1;HPGDS;GSS;GSTM6;SMS;GSTO1;GSTM5;CHAC2;RRM2B;SRM;GPX8;GSTT2;GPX1;NAT8F1;GGCT;IDH1;GPX4;GSTP1;GSTM7;MGST3;LAP3
gsea,Fluid shear stress and atherosclerosis,-0.43229407863908953,-1.9246606657774912,0.0,0.007516616752223496,0.066,34/111,16.82%,CALM1;CALM2;ACTB;SUMO2;CALM3;HSP90AB1;JUN;TXN1;ACTG1;NFE2L2;GSTM6;RAC1;TNFRSF1A;GSTO1;GSTM5;AKT3;TXN2;HSP90AA1;RHOA;CYBA;NCF1;BMPR1B;SQSTM1;BMPR1A;AKT1;CAV2;SDC4;IL1R2;BCL2;SUMO1;RELA;FOS;GSTT2;CTSL
gsea,Retrograde endocannabinoid signaling,-0.42352325267038843,-1.9237166577680473,0.0,0.007099026932655524,0.066,49/124,22.54%,NDUFA4;NDUFC1;NDUFB3;NDUFA1;NDUFA13;NDUFS5;NDUFA3;NDUFB10;NDUFB2;NDUFS8;KCNJ3;NDUFB11;RIMS1;NDUFB9;GNG7;NDUFA7;NDUFC2;NDUFAB1;NAPEPLD;NDUFB8;GRM1;NDUFS7;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;GABRB3;NDUFA11;PLCB1;SLC32A1;GABRG2;NDUFB5;NDUFA6;NDUFA12;NDUFA2;NDUFA10;CACNA1F;NDUFS1;NDUFB4;GRIA2;GABRB2;GNG3;MAPK3;NDUFB6;NDUFS2;NDUFA9;GNB2;NDUFS4
gsea,Phagosome,-0.4442203634253812,-1.9122553768367412,0.0,0.007491578055513891,0.075,48/101,25.99%,ATP6V0B;ACTB;TUBB2A;ATP6V1G2;ATP6V0C;TUBA1A;ACTG1;SEC61G;CALR;ATP6V1F;ATP6V0E2;TUBB2B;TUBB4B;CANX;TUBA4A;ATP6V1A;RAB5B;TUBB3;RAC1;TUBA1B;STX7;CYBA;NCF1;TUBB5;SEC61B;VAMP3;TUBB4A;ATP6V1G1;TFRC;THBS3;CTSL;RAB5A;H2-T22;TUBB6;ATP6V1D;RAB7;CTSS;ATP6V0E;H2-T24;STX18;ITGAV;ITGAM;ATP6V1E1;LAMP1;TLR4;ITGB1;ATP6V1B2;H2-T23
gsea,Drug metabolism,-0.47081855031065534,-1.8660638219926373,0.0,0.011807748594315643,0.118,14/51,12.46%,NME2;UCKL1;NME7;HPRT;HPGDS;GSTM6;TK2;GSTO1;GSTM5;NME4;TPMT;NME1;DUT;RRM2B
gsea,Legionellosis,-0.49776717342574245,-1.8454245079916727,0.0,0.014403450666255872,0.149,18/41,24.30%,EEF1A1;HSPA2;ARF1;EEF1G;HSPA8;CYCS;SAR1B;HSPD1;NLRC4;SAR1A;CASP8;NFKB2;RELA;PYCARD;ITGAM;IL18;NAIP2;TLR4
gsea,Starch and sucrose metabolism,0.562528493364572,1.7839278153907832,0.00186219739292365,0.14193703933319554,0.241,9/23,14.42%,AMY1;GPI1;PYGL;PYGM;HKDC1;GYS1;PGM2;AGL;GANC
gsea,Type II diabetes mellitus,0.4960452342928827,1.7484540028116742,0.005747126436781609,0.10454983812082386,0.323,11/37,7.97%,MTOR;MAPK10;INSR;CACNA1B;CACNA1A;IKBKB;PIK3R2;PRKCE;SOCS2;PIK3CD;HKDC1
gsea,Estrogen signaling pathway,-0.39111387003817744,-1.746011996048777,0.0,0.03374692780069041,0.309,26/101,16.16%,CALM1;CALM2;CALM3;HSP90AB1;HRAS;HSPA2;JUN;KRAS;GABBR1;HSPA8;KCNJ3;KRT10;AKT3;FKBP5;GRM1;HSP90AA1;TGFA;ATF2;PLCB1;GNAS;ATF4;AKT1;POMC;BCL2;FOS;MAP2K1
gsea,Prion diseases,-0.5209687726223309,-1.7388276893257937,0.008583690987124463,0.034670756742094175,0.325,15/25,32.10%,PRNP;C1QB;HSPA5;SOD1;MAP2K1;C1QC;MAPK3;C1QA;EGR1;PRKACA;C7;BAX;ELK1;MAP2K2;NOTCH1
gsea,Hippo signaling pathway,-0.3757088761201005,-1.6996870073943708,0.004228329809725159,0.04785103597011477,0.425,50/128,29.47%,ACTB;YWHAG;CTNNA3;FGF1;GSK3B;YWHAE;ACTG1;YWHAB;PARD6A;CTNNA1;TGFB1;YWHAH;PPP2R1A;CCND3;BMPR1B;PPP1CA;DVL1;PPP2CA;YWHAZ;BMPR1A;FBXW11;SMAD7;SMAD2;FZD1;ID2;PARD6G;WWTR1;NKD1;FZD9;YAP1;MOB1A;BMP8B;MYC;FZD2;DCHS1;FZD3;BBC3;ID1;WNT2B;FAT4;AXIN2;PPP2R1B;CCND2;DLG1;TRP53BP2;PRKCI;DLG2;LATS2;CRB2;SAV1
gsea,Renin secretion,-0.4221225267226837,-1.6856867930863029,0.008849557522123894,0.05156589386120312,0.45,13/57,15.68%,CALM1;CALM2;CALM3;CTSB;PTGER4;PPP3R1;PPP3CA;PDE3B;KCNJ2;PLCB1;GNAS;PDE3A;CACNA1F
gsea,Rheumatoid arthritis,-0.4584776057942054,-1.6815974796094226,0.008908685968819599,0.051448936182818955,0.456,9/43,4.50%,ATP6V0B;ATP6V1G2;ATP6V0C;JUN;ATP6V1F;ATP6V0E2;TEK;TGFB1;ATP6V1A
gsea,Biosynthesis of unsaturated fatty acids,-0.4855231265782992,-1.6729669680047417,0.014583333333333334,0.053976567648292215,0.481,14/28,23.60%,SCD2;TECR;HACD4;HSD17B12;HACD2;ACOT5;FADS2;ELOVL6;ACOT2;ELOVL4;ACOX1;ACOT3;ELOVL5;SCP2
gsea,Antigen processing and presentation,-0.4565023900311791,-1.671602629089152,0.018633540372670808,0.052626511592081954,0.482,16/42,20.96%,HSP90AB1;HSPA2;CALR;CTSB;HSPA8;CANX;HSPA5;HSP90AA1;NFYA;B2M;CTSL;H2-T22;RFXAP;IFI30;CTSS;H2-T24
gsea,Proximal tubule bicarbonate reclamation,-0.5574868326556265,-1.647039470344728,0.022821576763485476,0.06258050979131861,0.538,11/18,26.03%,ATP1B1;ATP1A2;MDH1;ATP1B2;SLC38A3;ATP1A1;SLC9A3;ATP1B3;FXYD2;CAR2;ATP1A3
gsea,Systemic lupus erythematosus,-0.5224898466361796,-1.6021475812894335,0.02771855010660981,0.08718323962104291,0.654,9/20,27.71%,H3F3A;H3F3B;C1QB;C2;SNRPD3;C1QC;SNRPB;C1QA;C7
gsea,Gastric acid secretion,-0.407527607065359,-1.601030824014027,0.008213552361396304,0.08546660272863024,0.657,12/59,11.60%,CALM1;CALM2;ACTB;ATP1B1;CALM3;ATP1A2;KCNK2;SSTR2;ATP1B2;KCNJ2;PLCB1;GNAS
gsea,Protein processing in endoplasmic reticulum,-0.3476780504034569,-1.5929992470554795,0.004098360655737705,0.0891646768851575,0.676,44/150,20.26%,HSP90AB1;SEC62;HSPA2;SEC61G;CALR;DAD1;HSPA8;CANX;HSPH1;PREB;NFE2L2;CRYAB;ERP29;SAR1B;DNAJA2;DNAJB12;HSPA5;SELENOS;SSR4;LMAN1;P4HB;HSP90AA1;XBP1;HSPBP1;SSR1;SEC61B;SSR2;RPN2;ATF4;SEC63;UBE2D2A;SAR1A;UBE2D3;DNAJA1;ATF6;BCL2;DNAJC1;LMAN2;DNAJC3;SSR3;BAG1;STUB1;EDEM1;UBE2J2
gsea,Central carbon metabolism in cancer,-0.38974529051637036,-1.592166018829547,0.012422360248447204,0.0868058229993068,0.676,20/60,20.98%,FGFR2;HRAS;KRAS;PGAM1;SIRT3;PKM;AKT3;SLC7A5;PDGFRA;NTRK3;AKT1;PGAM2;FGFR3;MAP2K1;PFKL;SCO2;MAPK3;MYC;EGFR;SIRT6
gsea,Alcoholism,-0.36156457991815494,-1.5891837226957668,0.006048387096774193,0.08644109265057019,0.688,15/89,12.43%,CALM1;CALM2;H3F3A;CALM3;H3F3B;HRAS;KRAS;GNG7;HDAC11;NPY;BDNF;PPP1CA;ATF2;GNAS;ATF4
gsea,Kaposi sarcoma-associated herpesvirus infection,-0.34049470415773253,-1.5876316989606258,0.0021141649048625794,0.08512670415158284,0.691,20/144,7.82%,CALM1;CALM2;UBB;CALM3;HRAS;GABARAPL1;GSK3B;JUN;KRAS;ANGPT2;GABARAP;LYN;CYCS;GABARAPL2;GNG7;PPP3R1;PPP3CA;RAC1;TNFRSF1A;AKT3
gsea,Neurotrophin signaling pathway,-0.3531040056125529,-1.5833072953717489,0.006134969325153374,0.08563762869393308,0.705,20/109,12.69%,CALM1;CALM2;CALM3;BEX3;HRAS;GSK3B;YWHAE;JUN;KRAS;MAGED1;CDC42;TRAF6;BDNF;RAC1;AKT3;ARHGDIG;RHOA;NTRK3;ATF4;AKT1
gsea,Vasopressin-regulated water reabsorption,-0.4338502035521484,-1.5809265137996922,0.024489795918367346,0.08515917905119168,0.71,12/38,16.86%,DYNLL2;VAMP2;DYNLL1;AQP4;RAB11A;RAB5B;DCTN1;ARHGDIG;NSF;GNAS;DCTN4;RAB5A
gsea,Regulation of actin cytoskeleton,-0.3395716820042667,-1.5769963711075365,0.002109704641350211,0.08500387145943887,0.721,68/175,30.20%,FGFR2;ACTB;TMSB4X;HRAS;CFL1;FGF1;ARPC3;ACTG1;KRAS;ARPC1B;CDC42;ARHGEF4;PFN2;ITGA8;ARPC2;PIP4K2A;PFN1;RAC1;WASL;ARPC5;PDGFRA;CFL2;RHOA;FGF10;PPP1CA;ABI2;FGFR3;MYL9;CXCL12;PDGFC;BCAR1;DIAPH2;BAIAP2;BRK1;MAP2K1;DOCK1;ARPC5L;WASF1;CXCR4;LPAR1;MAPK3;EGFR;FGF7;ITGAV;RAC3;ITGAM;MYL12A;MYH14;MYLK3;PXN;ITGB1;ITGA7;NCKAP1L;PAK2;ITGA10;ITGA4;TIAM1;ARHGEF1;MSN;FGF18;VCL;ITGB5;FGF9;PIP5K1B;MYL12B;IQGAP2;PPP1CC;DIAPH3
gsea,Gap junction,-0.3792450008202338,-1.5719978704574615,0.01646090534979424,0.08618370768875273,0.732,25/79,20.62%,TUBB2A;TUBA1A;HRAS;KRAS;HTR2B;TUBB2B;TUBB4B;TUBA4A;TUBB3;TUBA1B;GRM1;PDGFRA;GJA1;TUBB5;PLCB1;GNAS;TUBB4A;GJD2;PDGFC;PRKG1;MAP2K1;TUBB6;LPAR1;MAPK3;EGFR
gsea,Bacterial invasion of epithelial cells,-0.3959921592247934,-1.5683386910711175,0.017928286852589643,0.08706192713548487,0.737,20/62,17.96%,ACTB;CTNNA3;ARPC3;ACTG1;CLTB;CLTA;ARPC1B;CDC42;CTNNA1;ARPC2;RAC1;WASL;ELMO2;ARPC5;RHOA;CAV2;BCAR1;DOCK1;ARPC5L;WASF1
gsea,Lysine degradation,0.39924254489309396,1.5655856476835106,0.007736943907156673,0.36566324539046174,0.751,23/56,25.16%,EHMT1;KMT2D;SETD2;KMT2C;DHTKD1;ASH1L;CAMKMT;NSD1;NSD3;KMT2E;NSD2;EZH1;SETD1B;KMT2A;DOT1L;DLD;COLGALT2;SETD1A;GCDH;KMT2B;PLOD3;PRDM2;COLGALT1
gsea,Glycolysis / Gluconeogenesis,-0.40310622779574506,-1.5619627012917918,0.027600849256900213,0.08896248940922745,0.744,15/48,17.05%,GAPDH;ALDOA;PGAM1;TPI1;ENO2;MINPP1;ALDOC;GAPDHS;PKM;AKR1A1;PGK1;PGAM2;LDHB;BPGM;PFKL
gsea,Hepatitis C,-0.3441317835219895,-1.5566972404751724,0.0,0.09050296541631364,0.748,31/111,21.20%,YWHAG;HRAS;CD81;GSK3B;YWHAE;KRAS;YWHAB;CYCS;YWHAH;PPP2R1A;TRAF6;TNFRSF1A;AKT3;LDLR;PPP2CA;YWHAZ;AKT1;TYK2;CASP8;TLR3;CLDN5;FADD;RELA;MAP2K1;PPARA;PIAS1;MAPK3;MYC;IKBKG;EGFR;MAVS
gsea,Spliceosome,-0.3350013806907297,-1.5339261856751019,0.012072434607645875,0.10472370846312441,0.79,52/127,28.98%,DDX5;HSPA2;SNRPF;SNRPG;CCDC12;HSPA8;PRPF3;BCAS2;ZMAT2;SYF2;SNRNP27;LSM4;TXNL4A;SRSF2;SNU13;PRPF31;SF3B6;LSM7;SNRPD2;SNW1;PQBP1;MAGOHB;SF3B5;SNRNP70;RP9;CWC15;PUF60;U2AF1L4;PRPF19;SNRPB2;SNRPD3;U2AF2;U2AF1;SRSF9;SRSF10;PHF5A;PLRG1;LSM8;XAB2;MAGOH;PCBP1;ALYREF2;SNRPB;EIF4A3;THOC1;WBP11;LSM3;NCBP2;RBM8A;BUD31;HNRNPA1;SNRPC
gsea,Arginine and proline metabolism,-0.416804738566519,-1.5330668150040174,0.02834008097165992,0.10344646495767192,0.793,19/42,30.63%,ODC1;PRODH;CKB;HOGA1;SMS;SAT1;CNDP2;L3HYPDH;PYCRL;SRM;CKMT2;OAT;NOS3;P4HA1;AZIN2;SAT2;ARG2;LAP3;GAMT
gsea,Fatty acid elongation,-0.44202021615677783,-1.510906758646031,0.040983606557377046,0.1197309301907623,0.831,12/27,22.76%,TECR;HACD4;HSD17B12;HACD2;ACOT5;ELOVL6;ACOT2;ELOVL4;MECR;THEM4;ACOT3;ELOVL5
gsea,Synaptic vesicle cycle,-0.3893408404856388,-1.50106155668345,0.03977272727272727,0.12641112625540424,0.844,13/64,4.50%,ATP6V0B;ATP6V1G2;ATP6V0C;CPLX2;RAB3A;VAMP2;ATP6V1F;CPLX1;CLTB;CLTA;ATP6V0E2;RIMS1;ATP6V1A
gsea,B cell receptor signaling pathway,-0.383423875307092,-1.4981856349102742,0.03917525773195876,0.12613057009083892,0.847,25/62,24.54%,HRAS;CD81;GSK3B;JUN;KRAS;LYN;BTK;PPP3R1;PPP3CA;RAC1;AKT3;DAPP1;MALT1;AKT1;RELA;FOS;MAP2K1;MAPK3;IKBKG;INPPL1;RAC3;CR2;NFATC1;BLNK;CD72
gsea,Apoptosis,-0.32685443500816597,-1.4948556237181738,0.006578947368421052,0.12643456828159902,0.849,28/114,16.82%,ACTB;TUBA1A;HRAS;JUN;ACTG1;KRAS;CTSB;CYCS;TUBA4A;CTSZ;TNFRSF1A;TUBA1B;AKT3;DFFB;CTSC;BOK;ATF4;MCL1;AKT1;PARP3;CASP8;BCL2;GADD45A;FADD;RELA;FOS;MAP2K1;CTSL
gsea,Tuberculosis,-0.33855064378901456,-1.4859898229726272,0.022123893805309734,0.1317106986058692,0.861,30/109,19.98%,CALM1;CALM2;ATP6V0B;CALM3;ATP6V0C;CYCS;TGFB1;IFNGR2;RAB5B;CEBPB;PPP3R1;TRAF6;PPP3CA;TNFRSF1A;AKT3;RHOA;NFYA;HSPD1;MALT1;AKT1;CASP8;BCL2;FADD;RELA;RAB5A;RFXAP;CAMK2B;RAB7;CTSS;MAPK3
gsea,Bile secretion,-0.4001659888413711,-1.481972721749717,0.04526748971193416,0.1328937841793114,0.869,18/41,27.74%,ATP1B1;AQP4;NCEH1;ATP1A2;LDLR;ATP1B2;GNAS;ATP1A1;SLC9A3;HMGCR;ATP1B3;SLC10A1;KCNN2;FXYD2;CAR2;ATP1A3;PRKACA;ADCY9
gsea,Chemical carcinogenesis,-0.4210667880130057,-1.476528809764508,0.05251141552511415,0.13517223881002757,0.876,14/28,32.71%,HPGDS;GSTM6;GSTO1;GSTM5;CHRNA7;HSD11B1;CBR1;GSTT2;GSTP1;SULT1A1;GSTM7;ARNT;MGST3;ADH5
gsea,Salmonella infection,-0.3729833927930651,-1.4731632189448167,0.039832285115303984,0.13596330112158503,0.88,22/57,22.07%,ACTB;ARPC3;JUN;ACTG1;ARPC1B;CDC42;IFNGR2;PFN2;ARPC2;PFN1;RAC1;WASL;ARPC5;NLRC4;RELA;FOS;ARPC5L;WASF1;RAB7;MAPK3;PYCARD;IL18
gsea,Cellular senescence,-0.319527436453508,-1.4672216209516673,0.01126126126126126,0.13931861548992222,0.887,47/136,27.62%,CALM1;CALM2;SLC25A4;SLC25A5;CALM3;HRAS;VDAC1;KRAS;VDAC3;TGFB1;PPP3R1;PPP3CA;RHEB;AKT3;RBL1;CCND3;VDAC2;RAD9B;SQSTM1;PPP1CA;FBXW11;AKT1;LIN37;PPID;SMAD2;GADD45A;RELA;MAP2K1;H2-T22;TRAF3IP2;CCNE2;ETS1;MAPK3;MYC;H2-T24;FOXO1;E2F4;NFATC1;ITPR2;HIPK1;HIPK2;H2-T23;MRE11A;ZFP36L1;CCNB2;CCND2;FOXO3
gsea,Base excision repair,-0.4109325357845476,-1.4584536921660607,0.033112582781456956,0.14575470487047165,0.898,8/32,13.31%,HMGB1;POLD4;POLB;MPG;PCNA;POLE4;POLE3;PARP3
gsea,Citrate cycle (TCA cycle),-0.42968578171507094,-1.4578113357983484,0.0547945205479452,0.1439280737747964,0.899,8/28,20.65%,IDH3B;MDH2;SUCLG1;MDH1;IDH3G;SDHB;FH1;IDH1
gsea,Rap1 signaling pathway,-0.3088621354315522,-1.452645214299239,0.019271948608137045,0.1460948933220365,0.91,31/172,14.63%,CALM1;FGFR2;CALM2;ACTB;CALM3;HRAS;FGF1;RALA;ACTG1;KRAS;ANGPT2;TEK;PARD6A;CDC42;PFN2;PGF;PFN1;RAC1;AKT3;PDGFRA;RHOA;FGF10;P2RY1;PLCB1;GNAS;CSF1R;AKT1;FGFR3;VEGFB;PDGFC;BCAR1
gsea,Gastric cancer,-0.318840809907921,-1.4522193445856382,0.006578947368421052,0.14415612318943397,0.912,31/117,21.09%,FGFR2;CTNNA3;HRAS;FGF1;GSK3B;KRAS;CTNNA1;TGFB1;AKT3;MLH1;RPS6KB2;FGF10;RXRB;DVL1;AKT1;SMAD2;FZD1;BCL2;GADD45A;MAP2K1;TERT;FZD9;CCNE2;FRAT1;MAPK3;MYC;FZD2;EGFR;FGF7;FZD3;CDKN1B
gsea,Glyoxylate and dicarboxylate metabolism,-0.4181305596005267,-1.4409474439503935,0.059670781893004114,0.1537182575622764,0.928,9/27,16.68%,HYI;MDH2;HOGA1;MCEE;MDH1;GLUL;PGP;AFMID;GLYCTK
gsea,Glutamatergic synapse,0.34651727191124515,1.4386326269892409,0.04263565891472868,0.7125955775986773,0.941,42/102,20.63%,DLGAP1;GRIN1;GRIA4;GRIK4;SHANK1;CACNA1A;ADCY8;PRKCG;GRK3;GRIK5;PRKCB;PPP3R2;PLD2;DLG4;SLC17A6;PRKCA;SLC1A1;PPP3CB;ADCY1;SHANK3;PPP3CC;GRIN2D;GRIK3;PLA2G4E;GRM4;GRK2;GRIK1;GRM5;ADCY6;GRIN3A;PLA2G4A;CACNA1C;GNB5;PLD1;SHANK2;GRM2;PLCB4;ADCY3;ADCY2;ADCY7;GRIA3;ADCY5
gsea,cGMP-PKG signaling pathway,-0.3218420899165025,-1.4324639072303074,0.026607538802660754,0.1598857436778473,0.935,53/135,30.30%,CALM1;CALM2;ATP1B1;SLC25A4;SLC25A5;CALM3;VDAC1;VDAC3;PPP3R1;PPP3CA;ATP1A2;PDE3B;AKT3;IRS2;ATP1B2;VDAC2;RHOA;PPP1CA;ATF2;PLCB1;ATF4;AKT1;MYL9;ATP1A1;PDE3A;PRKG1;CACNA1F;MAP2K1;PIK3CG;ATP1B3;ATP2B1;MAPK3;RGS2;CREB3;NFATC1;MYLK3;ITPR2;FXYD2;NOS3;CREB5;ADRA1D;ATP1A3;ADRA2C;PLCB2;EDNRA;MYH7;PPIF;ADCY9;GUCY1B1;CREB3L1;PPP1CC;GNA11;BAD
gsea,Peroxisome,-0.3347885433877158,-1.424790607479915,0.03070175438596491,0.16533543865054304,0.945,22/77,24.48%,PRDX5;NUDT19;ABCD3;ACSL3;PEX11A;CROT;GNPAT;AGPS;SOD1;MPV17L2;PIPOX;PEX7;PEX26;PEX10;PEX19;ACOX1;IDH1;AMACR;SOD2;PECR;SCP2;ACOX2
gsea,Colorectal cancer,-0.3262992212414036,-1.424442141991978,0.03292181069958848,0.1631288330389172,0.945,24/82,21.13%,HRAS;GSK3B;RALA;JUN;KRAS;CYCS;TGFB1;RAC1;AKT3;MLH1;RHOA;RPS6KB2;TGFA;AKT1;SMAD2;BCL2;GADD45A;FOS;MAP2K1;MAPK3;MYC;DCC;EGFR;RAC3
gsea,Thyroid hormone synthesis,-0.35957359721256404,-1.4188772254431774,0.044642857142857144,0.16709816559123222,0.947,23/57,27.74%,ATP1B1;TTR;CANX;HSPA5;ATP1A2;ATP1B2;TTF1;ATF2;PLCB1;GNAS;ATF4;GPX8;ATP1A1;GPX1;ATP1B3;CREB3;ITPR2;FXYD2;CREB5;ATP1A3;PLCB2;PRKACA;ADCY9
gsea,Insulin resistance,0.33412636221111425,1.416212899075629,0.031598513011152414,0.6623131500998828,0.961,31/91,17.61%,MTOR;MAPK10;INSR;PYGL;OGT;IKBKB;RPS6KA2;SLC27A5;CPT1B;PIK3R2;PRKCB;CREB3L3;PYGM;PRKCE;MLXIPL;PIK3CD;AKT2;GYS1;PTPRF;PRKAG1;RPS6KB1;RPS6KA6;PRKAA2;PPARGC1B;CRTC2;PIK3CA;PRKCZ;PCK2;SLC27A3;NR1H2;MAPK8
gsea,Other glycan degradation,0.46405077723274607,1.413215574527104,0.07884615384615384,0.5651362770085646,0.963,4/18,6.40%,HEXB;HEXDC;MAN2C1;NEU2
gsea,Selenocompound metabolism,-0.4809779758222793,-1.413147918502884,0.08050847457627118,0.17019692418290586,0.949,5/15,14.22%,PAPSS2;PSTK;MARS2;SEPHS2;TXNRD1
gsea,Metabolism of xenobiotics by cytochrome P450,-0.4160221271316806,-1.408997366923644,0.07095343680709534,0.17213736231995685,0.951,12/24,32.71%,HPGDS;GSTM6;GSTO1;GSTM5;HSD11B1;CBR1;GSTT2;GSTP1;GSTM7;MGST3;DHDH;ADH5
gsea,Olfactory transduction,-0.40551581770204964,-1.4009086973162357,0.09611451942740286,0.17775078653149975,0.957,4/33,5.42%,CALM1;CALM2;CALM3;GNG7
gsea,N-Glycan biosynthesis,-0.3616862472977591,-1.4006377068695315,0.03822937625754527,0.17537619124309412,0.957,13/49,20.58%,DPM1;DPM2;ALG11;DAD1;DOLK;DPM3;ALG5;MGAT4B;RPN2;MGAT2;ALG12;ALG13;ALG2
gsea,Collecting duct acid secretion,-0.4708542778125204,-1.3979464072767402,0.08943089430894309,0.1760419193411361,0.959,5/19,4.50%,ATP6V1G2;ATP6V0C;ATP6V1F;ATP6V0E2;ATP6V1A
gsea,Intestinal immune network for IgA production,-0.45826892664367097,-1.3932709912861068,0.08126410835214447,0.17930461100715414,0.961,9/18,29.71%,TGFB1;CXCL12;CXCR4;ICOSL;CCL25;ITGA4;IL4;CCR9;TNFSF13B
gsea,PPAR signaling pathway,-0.35390142905515626,-1.3906573784142153,0.039045553145336226,0.17949559457350583,0.962,22/51,29.06%,SCD2;CPT1C;PLTP;APOA1;UBC;FABP3;ACSL3;RXRB;FADS2;DBI;PPARA;ACOX1;CPT2;FABP5;SCP2;RXRG;ACOX2;CPT1A;NR1H3;SLC27A1;PPARG;PLIN5
gsea,PI3K-Akt signaling pathway,-0.2789580205732304,-1.389577598128979,0.014251781472684086,0.17813294307941155,0.962,90/269,29.97%,FGFR2;YWHAG;HSP90AB1;HRAS;FGF1;GSK3B;YWHAE;KRAS;MLST8;YWHAB;ANGPT2;TEK;DDIT4;COL4A2;YWHAH;GNG7;ITGA8;PPP2R1A;PGF;BDNF;RAC1;RHEB;AKT3;COL6A1;PDGFRA;CCND3;HSP90AA1;RPS6KB2;FGF10;TGFA;PPP2CA;ATF2;YWHAZ;CSF1R;ATF4;RPS6;MCL1;AKT1;FGFR3;NR4A1;LAMC3;VEGFB;PDGFC;LAMB1;BCL2;RELA;MAP2K1;THBS3;VEGFC;PIK3CG;COL9A2;STK11;CCNE2;LPAR1;GNG3;MAPK3;LAMA5;MYC;IKBKG;EGFR;FGF7;CREB3;CDKN1B;ITGAV;MAGI2;GNB2;PPP2R5B;THEM4;TLR4;G6PC3;EFNA3;ITGB1;ITGA7;NOS3;CREB5;ITGA10;ITGA4;GNG10;IL4;PPP2R1B;CCND2;FOXO3;PHLPP1;FGF18;FLT1;ITGB5;FGF9;LAMB3;CDK4;CREB3L1
gsea,Pyrimidine metabolism,-0.35347822704787224,-1.3838310366860687,0.06209850107066381,0.1820484642430567,0.964,25/48,36.24%,NME2;UCKL1;NME7;TK2;DTYMK;NME4;NME1;DUT;RRM2B;ENTPD1;DCK;AK9;CMPK2;CANT1;UCK1;PNP;DHODH;DCTPP1;NUDT2;ENPP1;DPYS;NT5C1A;TYMS;CAD;DPYD
gsea,NOD-like receptor signaling pathway,-0.30322711867158864,-1.3758802404715011,0.0343980343980344,0.1890677552697117,0.971,32/116,22.07%,HSP90AB1;GABARAPL1;VDAC1;JUN;TXN1;GABARAP;CTSB;VDAC3;GABARAPL2;AIM2;TRAF6;TXN2;HSP90AA1;VDAC2;RHOA;CYBA;PLCB1;NLRC4;TYK2;CASP8;NEK7;BCL2;FADD;RELA;CARD6;ATG12;MAPK3;GSDMD;IKBKG;MAVS;PYCARD;IL18
gsea,Viral carcinogenesis,-0.29665291207919425,-1.3727291774518329,0.02813852813852814,0.19004514860845426,0.975,37/143,21.71%,UBE3A;YWHAG;HRAS;YWHAE;JUN;KRAS;YWHAB;PSMC1;LYN;VDAC3;CDC42;YWHAH;POLB;HDAC11;PKM;RAC1;DNAJA3;RBL1;CCND3;SNW1;RHOA;ATF2;YWHAZ;ATF4;GTF2B;RANBP1;CASP8;NFKB2;RELA;H2-T22;CCNE2;MAPK3;IKBKG;CREB3;H2-T24;CDKN1B;GTF2E2
gsea,Human immunodeficiency virus 1 infection,-0.28972049908539554,-1.3703474045531154,0.033126293995859216,0.19042781516785984,0.977,43/166,21.13%,CALM1;CALM2;CALM3;HRAS;CFL1;JUN;CALR;KRAS;CYCS;ELOB;GNG7;PPP3R1;TRAF6;PPP3CA;PTK2B;RAC1;TNFRSF1A;AKT3;AP1S1;CFL2;RPS6KB2;B2M;AP1S3;FBXW11;CD247;AKT1;RNF7;CASP8;BCL2;FADD;RELA;FOS;MAP2K1;H2-T22;CDC25C;CGAS;CXCR4;GNG3;MAPK3;AP1S2;IKBKG;H2-T24;RAC3
gsea,Salivary secretion,-0.3533380703278753,-1.3661220398718874,0.07775377969762419,0.19300007702380034,0.978,6/59,1.25%,CALM1;CALM2;CST3;ATP1B1;CALM3;VAMP2
gsea,C-type lectin receptor signaling pathway,-0.32195797347372407,-1.3653979061797843,0.053830227743271224,0.19148218115187068,0.979,15/79,16.01%,CALM1;CALM2;CALM3;HRAS;JUN;KRAS;PPP3R1;PPP3CA;AKT3;RHOA;MALT1;AKT1;CASP8;NFKB2;RELA
gsea,Steroid hormone biosynthesis,-0.4446885659342572,-1.3617929655734182,0.12334801762114538,0.1933017302346425,0.98,8/18,31.98%,CYP7B1;HSD17B12;DHRS11;HSD11B1;HSD3B6;HSD17B7;SRD5A3;HSD17B2
gsea,Folate biosynthesis,-0.43778708669241734,-1.3613858358175586,0.1007905138339921,0.19140414388045907,0.98,9/17,35.94%,PCBD1;CBR1;GPHN;AKR1B10;QDPR;MOCOS;GGH;PTS;AKR1B3
gsea,Prostate cancer,-0.31803327589222696,-1.3604161754945754,0.06198347107438017,0.19008693939591892,0.982,23/84,21.09%,FGFR2;HSP90AB1;HRAS;GSK3B;KRAS;AKT3;PDGFRA;HSP90AA1;TGFA;ATF4;AKT1;PDGFC;IL1R2;BCL2;RELA;MAP2K1;CCNE2;MAPK3;IKBKG;EGFR;CREB3;FOXO1;CDKN1B
gsea,Melanogenesis,-0.32296876931503865,-1.3583106476899187,0.05714285714285714,0.19009666486944468,0.982,19/79,21.03%,CALM1;CALM2;CALM3;HRAS;GSK3B;KRAS;DVL1;PLCB1;GNAS;A;FZD1;POMC;MAP2K1;FZD9;CAMK2B;MAPK3;FZD2;CREB3;FZD3
gsea,Endocrine and other factor-regulated calcium reabsorption,-0.37638311771462923,-1.3508676169160847,0.103515625,0.19621670503593017,0.984,20/38,27.74%,ATP1B1;CLTB;CLTA;RAB11A;ATP1A2;ATP1B2;CALB1;AP2M1;PLCB1;GNAS;ATP1A1;ATP1B3;ATP2B1;AP2B1;AP2S1;FXYD2;ATP1A3;PLCB2;PRKACA;ADCY9
gsea,Pyruvate metabolism,-0.37826463633991425,-1.3486238288560886,0.09486166007905138,0.19678265950032217,0.985,7/33,14.60%,GLO1;MDH2;ACOT12;PKM;MDH1;HAGH;LDHB
gsea,Chagas disease (American trypanosomiasis),-0.32104526185847404,-1.3437338395122043,0.06997742663656885,0.2002386809813389,0.987,20/75,16.18%,JUN;CALR;TGFB1;IFNGR2;C1QB;PPP2R1A;TRAF6;TNFRSF1A;AKT3;PPP2CA;PLCB1;GNAS;CD247;AKT1;SMAD2;CASP8;FADD;RELA;FOS;C1QC
gsea,Endometrial cancer,-0.32880415810760677,-1.3391113282311877,0.08757637474541752,0.2036316721867057,0.988,20/56,31.11%,CTNNA3;HRAS;GSK3B;KRAS;CTNNA1;AKT3;MLH1;AKT1;GADD45A;MAP2K1;MAPK3;MYC;EGFR;DDB2;AXIN2;FOXO3;BAX;ELK1;BAD;MAP2K2
gsea,Osteoclast differentiation,-0.3112514367203925,-1.333429278020285,0.08390022675736962,0.20814368110334328,0.99,24/97,16.16%,JUN;JUNB;TGFB1;IFNGR2;BTK;PPP3R1;TRAF6;PPP3CA;JUND;RAC1;TNFRSF1A;AKT3;SOCS1;CYBA;NCF1;SQSTM1;CSF1R;AKT1;TYK2;TYROBP;NFKB2;RELA;FOS;MAP2K1
gsea,Cytosolic DNA-sensing pathway,-0.3693678057364921,-1.3286805384087543,0.10669456066945607,0.2118924747747054,0.991,16/36,23.45%,POLR3H;AIM2;POLR1C;POLR3E;POLR1D;POLR2F;POLR3A;RELA;POLR3K;CGAS;POLR2E;IKBKG;MAVS;PYCARD;IL18;POLR3D
gsea,ABC transporters,0.3747305785908847,1.328513794915752,0.09411764705882353,0.8339680571546658,0.996,14/35,23.29%,ABCC5;ABCA1;ABCA9;ABCA8B;ABCB6;ABCG1;ABCA17;ABCA5;ABCB9;ABCA3;ABCG4;ABCA6;ABCC1;ABCC8
gsea,Steroid biosynthesis,-0.452345044548516,-1.3228027470243762,0.14124293785310735,0.21683793395607517,0.991,8/15,29.71%,FDFT1;MSMO1;CYP51;EBP;SQLE;HSD17B7;SC5D;DHCR7
gsea,Ras signaling pathway,-0.2738470069736963,-1.3199599555791375,0.06097560975609756,0.21828895128594733,0.991,42/184,21.13%,CALM1;FGFR2;CALM2;CALM3;HRAS;FGF1;RALA;KRAS;ANGPT2;TEK;CDC42;RAB5B;GNG7;ETS2;PGF;RASAL2;PLA2G3;BDNF;RAC1;AKT3;PDGFRA;RHOA;RASA1;FGF10;TGFA;CSF1R;AKT1;FGFR3;VEGFB;PDGFC;RELA;MAP2K1;RAB5A;VEGFC;ETS1;GNG3;MAPK3;IKBKG;EGFR;FOXO4;FGF7;RAC3
gsea,Ubiquitin mediated proteolysis,0.29019705092812054,1.3177716035523666,0.06626506024096386,0.7793664324584969,0.996,36/126,16.71%,HERC1;HUWE1;UBR5;BIRC6;UBE2E2;HERC2;SMURF1;PRKN;ANAPC1;SMURF2;UBE4B;TRIP12;ANAPC5;MDM2;UBE3C;CUL4A;PIAS4;HERC4;UBE4A;CDC23;CUL4B;CBL;ANAPC11;UBE2O;ITCH;CDC27;UBA6;TRIM37;XIAP;UBOX5;NEDD4;CUL2;WWP1;PIAS2;UBE2L3;MGRN1
gsea,Cysteine and methionine metabolism,-0.3593965196600081,-1.3122234695262196,0.12684989429175475,0.225941096697756,0.993,8/38,14.60%,MDH2;GSS;AHCYL1;SMS;MDH1;AHCYL2;SRM;LDHB
gsea,Long-term potentiation,-0.3459055561725132,-1.3086570232424393,0.12922465208747516,0.2283190839302678,0.993,12/61,12.43%,CALM1;CALM2;CALM3;HRAS;PPP1R1A;KRAS;PPP3R1;PPP3CA;GRM1;PPP1CA;PLCB1;ATF4
gsea,Inflammatory bowel disease (IBD),-0.38692918793553327,-1.2986896037517472,0.14285714285714285,0.23926554843908304,0.994,11/25,26.73%,JUN;TGFB1;IFNGR2;SMAD2;RELA;IL12RB2;IL21R;IL18;NFATC1;TLR4;IL4
gsea,Human papillomavirus infection,-0.2548599514334886,-1.2911433434472557,0.04215456674473068,0.24731923686158153,0.995,96/269,31.11%,UBE3A;ATP6V0B;ATP6V1G2;ATP6V0C;HRAS;GSK3B;KRAS;ATP6V1F;PSMC1;ATP6V0E2;PARD6A;CDC42;ATP6V1A;PTGER4;COL4A2;ITGA8;PPP2R1A;HES1;PKM;TNFRSF1A;RHEB;MAML3;AKT3;COL6A1;RBL1;CCND3;RPS6KB2;TUBG2;DVL1;PPP2CA;GNAS;AKT1;TYK2;LAMC3;FZD1;CASP8;LAMB1;ATP6V1G1;TLR3;PARD6G;FADD;RELA;MAP2K1;THBS3;JAG1;TADA3;H2-T22;TERT;MAML2;ATP6V1D;COL9A2;FZD9;CCNE2;MAPK3;ATP6V0E;LAMA5;IKBKG;FZD2;IRF1;EGFR;CREB3;H2-T24;FZD3;FOXO1;CDKN1B;ITGAV;PPP2R5B;ATP6V1E1;LFNG;PXN;ITGB1;ITGA7;WNT2B;ATP6V1B2;CREB5;H2-T23;ITGA10;ITGA4;PRKACA;AXIN2;PPP2R1B;HES5;CCND2;DLG1;BAX;PRKCI;DLG2;ITGB5;TRADD;LAMB3;CDK4;CREB3L1;BAD;TICAM1;ITGA11;MAP2K2
gsea,GnRH signaling pathway,-0.30591456546671686,-1.279450041471019,0.10460251046025104,0.2616871193844059,0.996,7/76,4.20%,CALM1;CALM2;CALM3;HRAS;JUN;KRAS;CDC42
gsea,RNA transport,-0.27669497399405424,-1.2791403790774885,0.0744466800804829,0.25938502231232,0.996,60/146,35.70%,EEF1A1;SUMO2;EIF1;PABPC4;POP5;RAN;RPP21;EIF4G2;STRAP;POP7;EIF2B4;NUP43;EIF2B1;EIF3C;EIF5;NXT2;FMR1;MAGOHB;RPP25L;RPP38;NUP50;PABPC1;EIF1B;RPP25;SUMO1;PHAX;EIF4EBP2;EIF2S2;PABPC1L;EIF1A;ELAC2;SAP18;MAGOH;NUP35;ALYREF2;EIF4A3;THOC1;EIF3F;THOC6;EIF2B5;NCBP2;RBM8A;GEMIN7;GEMIN4;SUMO3;NXT1;EIF4A2;THOC3;UBE2I;EIF3H;PRMT5;SMN1;EIF1AX;EIF4E;EIF3D;KPNB1;EEF1A2;POP4;XPO1;NUP37
gsea,Other types of O-glycan biosynthesis,0.39806525947937005,1.2780375371484292,0.15444015444015444,0.8746067828522881,0.997,10/21,19.33%,ST3GAL3;OGT;B3GLCT;GXYLT1;POMT1;B4GALT2;EOGT;POFUT1;ST6GAL1;COLGALT2
gsea,Melanoma,-0.3125048433235789,-1.277406382995645,0.12364425162689804,0.2594299427996935,0.996,20/61,31.11%,HRAS;FGF1;KRAS;AKT3;PDGFRA;FGF10;AKT1;PDGFC;GADD45A;MAP2K1;MAPK3;EGFR;FGF7;DDB2;BAX;FGF18;FGF9;CDK4;BAD;MAP2K2
gsea,Ribosome biogenesis in eukaryotes,-0.29071409914180196,-1.2726341965442522,0.09,0.2639389008703689,0.996,15/74,13.80%,POP5;FBLL1;IMP3;RAN;NOP10;EIF6;POP7;SNU13;NXT2;AK6;RPP25L;RPP38;NOB1;RPP25;CSNK2B
gsea,Viral myocarditis,-0.35351598179101557,-1.2718299299053863,0.1272365805168986,0.26263527801224595,0.996,10/36,21.13%,ACTB;ACTG1;CYCS;EIF4G2;RAC1;CASP8;SGCB;H2-T22;H2-T24;RAC3
gsea,DNA replication,-0.35117079801181106,-1.270771436841032,0.13656387665198239,0.261572826003235,0.996,8/33,18.58%,POLD4;PCNA;POLE4;MCM2;POLE3;SSBP1;POLA2;MCM6
gsea,Oocyte meiosis,-0.2919065057427597,-1.2689392600676768,0.1115702479338843,0.26159383249424073,0.996,15/95,12.16%,CALM1;CALM2;YWHAG;CALM3;YWHAE;YWHAB;ANAPC13;YWHAH;PPP3R1;PPP2R1A;PPP3CA;PPP1CA;PPP2CA;YWHAZ;FBXW11
gsea,Apelin signaling pathway,-0.2897733251776342,-1.2655299421284512,0.11328976034858387,0.2638950935839175,0.996,17/111,13.69%,CALM1;CALM2;CALM3;HRAS;GABARAPL1;KRAS;GABARAP;GABARAPL2;GNG7;ACTA2;PDE3B;AKT3;RPS6KB2;PLCB1;RPS6;AKT1;SMAD2
gsea,Nicotine addiction,0.3710180606643518,1.2653969350637295,0.1640625,0.8417269408279948,0.998,5/33,2.43%,GRIN1;GRIA4;CACNA1B;CACNA1A;GABRG3
gsea,Glucagon signaling pathway,-0.30054511843548287,-1.2639428792392438,0.125,0.26360442406406553,0.996,30/83,26.75%,CALM1;CALM2;CALM3;CPT1C;PGAM1;PPP3R1;PPP3CA;PKM;PDE3B;AKT3;ATF2;PLCB1;GNAS;ATF4;AKT1;PGAM2;LDHB;PPARA;PFKL;PFKFB1;CAMK2B;CREB3;FOXO1;SIK1;G6PC3;ITPR2;CREB5;CPT1A;PLCB2;PRKACA
gsea,Aldosterone synthesis and secretion,-0.30531707805519537,-1.2609243418685008,0.10660980810234541,0.26507967432524887,0.996,32/82,30.19%,CALM1;CALM2;ATP1B1;CALM3;STAR;ATP1A2;LDLR;ATP1B2;CAMK1;ATF2;PLCB1;GNAS;ATF4;NR4A1;ATP1A1;POMC;CACNA1F;ATP1B3;ATP2B1;CAMK2B;CREB3;HSD3B6;ITPR2;PRKD1;CREB5;ATP1A3;PLCB2;PRKACA;ADCY9;CAMK1G;CREB3L1;GNA11
gsea,Mitophagy,-0.31171724586358124,-1.2525603149036315,0.13137254901960785,0.2754303798320283,0.996,20/62,24.66%,UBB;HRAS;GABARAPL1;JUN;KRAS;GABARAP;GABARAPL2;BNIP3L;SQSTM1;ATF4;CSNK2B;TOMM7;RELA;ATG9A;RAB7;TFEB;CITED2;ATG9B;FUNDC1;FIS1
gsea,Endocytosis,-0.2603128591676962,-1.252482446641596,0.09240246406570841,0.2728908809745288,0.996,59/219,22.44%,FGFR2;UBB;HRAS;HSPA2;ARF1;ARPC3;CLTB;CLTA;WIPF3;SNX3;ARPC1B;HSPA8;PARD6A;CDC42;RAB11A;RAB5B;SH3GL1;CAPZA2;ARPC2;TRAF6;WASL;LDLR;ARPC5;PDGFRA;CHMP2A;CHMP5;RHOA;CHMP4B;STAM2;MVB12B;SPG21;AP2M1;SMAP1;FGFR3;CAV2;SMAD2;TFRC;CYTH3;PARD6G;VPS29;RAB5A;CHMP4C;VPS37C;EHD1;H2-T22;ARPC5L;ARF5;CHMP1A;RAB7;CXCR4;AP2B1;CAPZA1;EHD3;EGFR;H2-T24;VPS26B;RAB35;VPS4A;AP2S1
gsea,Human cytomegalovirus infection,-0.2663071280832096,-1.2518881760837572,0.07894736842105263,0.27104675344681506,0.996,44/181,21.13%,CALM1;CALM2;CALM3;HRAS;GSK3B;CALR;KRAS;CYCS;PTGER4;GNG7;PPP3R1;PPP3CA;PTK2B;RAC1;TNFRSF1A;RHEB;AKT3;PDGFRA;RHOA;RPS6KB2;B2M;ATF2;PLCB1;GNAS;ATF4;AKT1;CXCL12;CASP8;BCAR1;FADD;RELA;MAP2K1;H2-T22;CGAS;CXCR4;GNG3;MAPK3;MYC;IKBKG;EGFR;CREB3;H2-T24;ITGAV;RAC3
gsea,Epstein-Barr virus infection,-0.26016589962365033,-1.2517412531630696,0.07586206896551724,0.2687186000851622,0.996,50/150,27.97%,JUN;PSMD7;CALR;PSMC6;PSMC1;LYN;CYCS;PSMC3;BTK;HES1;TRAF6;RAC1;PSMC5;AKT3;CCND3;SNW1;B2M;PSMD11;CD247;AKT1;TYK2;CASP8;BCL2;GADD45A;NFKB2;FADD;RELA;ENTPD1;SEM1;H2-T22;PSMD2;CCNE2;MYC;IKBKG;H2-T24;CDKN1B;MAVS;SIN3A;PSMC2;CR2;BLNK;DDB2;H2-T23;SAP30;VIM;PSMD4;PSMD8;CCND2;CIR1;BAX
gsea,Autophagy,-0.27928714863739085,-1.2484609251329806,0.09690721649484536,0.2708178415915565,0.996,29/123,19.98%,HMGB1;HRAS;GABARAPL1;KRAS;MLST8;GABARAP;CTSB;ATG16L2;GABARAPL2;DDIT4;RRAGA;TRAF6;RHEB;AKT3;IRS2;RPS6KB2;ATG10;PPP2CA;AKT1;BCL2;MAP2K1;CTSL;ATG9A;RRAGD;STK11;RAB7;ATG101;ATG12;MAPK3
gsea,Choline metabolism in cancer,0.2920767120566865,1.2446436903121294,0.13001912045889102,0.858175681176301,0.998,31/90,18.50%,MTOR;SLC44A2;DGKG;MAPK10;DGKQ;RALGDS;DGKA;PRKCG;PIK3R2;GRB2;PRKCB;TSC1;PLD2;PRKCA;SLC22A4;PIK3CD;AKT2;DGKZ;RPS6KB1;SLC22A21;LYPLA1;SLC5A7;PLA2G4E;CHKA;PIK3CA;PLA2G4A;PIP5K1C;MAPK8;DGKI;PLD1;PIP5K1A
gsea,Oxytocin signaling pathway,-0.2801809365100259,-1.2424872444083395,0.10991379310344827,0.27755098547673457,0.997,25/136,16.16%,CALM1;CALM2;ACTB;CALM3;HRAS;JUN;ACTG1;KRAS;MYL6;KCNJ3;PPP3R1;PPP3CA;CAMK1;RHOA;KCNJ2;PPP1CA;PLCB1;GNAS;MYL9;CD38;CACNB3;EEF2;CACNA1F;FOS;MAP2K1
gsea,Phospholipase D signaling pathway,0.2827412736168134,1.2395900101948871,0.12754158964879853,0.8090858992904869,0.998,44/125,20.08%,MTOR;DGKG;INSR;DNM2;DNM1;RAPGEF4;DGKQ;RALGDS;DGKA;ADCY8;SHC1;SHC3;PIK3R2;GRB2;TSC1;PLD2;KITL;DNM3;PRKCA;PIK3CD;AKT2;DGKZ;ADCY1;PLA2G4E;RRAS2;GRM4;PIK3CA;GRM5;LPAR2;ADCY6;PLA2G4A;FYN;PIP5K1C;RAPGEF3;KIT;DGKI;PLD1;PIP5K1A;GRM2;SOS2;PLCB4;ADCY3;ADCY2;ADCY7
gsea,Glioma,-0.29899161981426337,-1.2395777124163063,0.13807531380753138,0.2790558154029228,0.997,9/70,9.87%,CALM1;CALM2;CALM3;HRAS;KRAS;AKT3;PDGFRA;CAMK1;TGFA
gsea,SNARE interactions in vesicular transport,-0.35181637115715386,-1.2386533818684293,0.1744421906693712,0.2775923760441976,0.997,12/31,25.97%,VAMP2;STX19;STX7;BET1;VAMP3;VTI1B;STX16;BET1L;STX18;VAMP1;GOSR2;YKT6
gsea,Carbohydrate digestion and absorption,-0.3542812557521895,-1.2374747225969323,0.15,0.2771170616044682,0.997,14/29,28.60%,ATP1B1;LCT;ATP1A2;AKT3;ATP1B2;SLC2A5;AKT1;ATP1A1;ATP1B3;G6PC3;FXYD2;ATP1A3;PLCB2;HK2
gsea,RNA degradation,-0.2892401992411535,-1.2357887741428113,0.13617021276595745,0.2769101902487869,0.997,21/72,21.54%,BTG1;PABPC4;ENO2;CNOT6L;CNOT8;LSM4;LSM7;PNPT1;HSPD1;NUDT16;PABPC1;LSM1;ZCCHC7;EXOSC7;CNOT3;PFKL;EXOSC5;CNOT4;PABPC1L;ENO4;LSM8
gsea,mTOR signaling pathway,-0.2690192123372121,-1.2344686536069005,0.1069182389937107,0.2765924670723254,0.997,33/131,21.03%,ATP6V1G2;HRAS;GSK3B;LAMTOR2;KRAS;MLST8;ATP6V1F;LAMTOR3;ATP6V1A;DDIT4;RRAGA;TNFRSF1A;LAMTOR1;RHEB;CAB39L;AKT3;SLC7A5;RHOA;RPS6KB2;DVL1;RPS6;AKT1;FZD1;SLC3A2;ATP6V1G1;MAP2K1;RRAGD;ATP6V1D;FZD9;STK11;MAPK3;FZD2;FZD3
gsea,Amphetamine addiction,-0.31309159127793634,-1.2327271365504981,0.1717171717171717,0.2765924670723254,0.997,16/58,21.88%,CALM1;CALM2;CALM3;JUN;PPP3R1;PPP3CA;PPP1CA;ATF2;GNAS;ATF4;FOS;PPP1R1B;GRIA2;CAMK2B;CREB3;SLC18A2
gsea,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.3698380761116624,-1.2229692148326785,0.1868583162217659,0.2888432699617225,0.999,5/25,14.79%,PIGK;DPM2;PIGYL;PIGP;PIGW
gsea,Phosphatidylinositol signaling system,0.2867246795915888,1.2227130167997888,0.16895874263261296,0.8172831852311083,0.998,35/92,19.29%,DGKG;PIKFYVE;DGKQ;DGKA;PI4KA;PPIP5K1;PRKCG;INPP5K;SYNJ1;PIK3R2;PRKCB;PIK3C2B;OCRL;IP6K1;PRKCA;PIK3CD;DGKZ;PI4K2B;INPP5B;INPP5J;MTM1;MTMR2;SYNJ2;PIK3CA;INPP4A;PIK3C2G;MTMR14;PIP5K1C;ITPKC;IPMK;DGKI;PIP5K1A;PLCD3;INPP5A;PLCB4
gsea,Complement and coagulation cascades,-0.351697378411879,-1.2212887472271747,0.19594594594594594,0.28923964229084714,0.999,19/31,39.67%,C1QB;CLU;MASP2;F3;C2;C1QC;SERPING1;ITGAM;CR2;C1QA;SERPINC1;CFH;C7;MASP1;A2M;VTN;CD55;PLAT;TFPI
gsea,IL-17 signaling pathway,-0.3053307940237372,-1.2191146561315496,0.15856236786469344,0.2904725508900199,0.999,16/55,20.37%,HSP90AB1;GSK3B;JUN;CEBPB;TRAF6;JUND;ELAVL1;HSP90AA1;CASP8;FADD;RELA;FOS;TRAF3IP2;IL17RB;MAPK3;IKBKG
gsea,Signaling pathways regulating pluripotency of stem cells,-0.2702072065504413,-1.2120803469569805,0.1292372881355932,0.29905926524516413,0.999,28/103,25.71%,FGFR2;HRAS;GSK3B;KRAS;JARID2;ID3;AKT3;ONECUT1;INHBA;BMPR1B;DVL1;BMPR1A;AKT1;FGFR3;SMAD2;FZD1;ID2;MAP2K1;FZD9;MAPK3;MYC;FZD2;FZD3;PCGF1;ID1;SKIL;WNT2B;KAT6A
gsea,Pathways in cancer,-0.2311286093838589,-1.2117407682442982,0.06633906633906633,0.2970626747194295,0.999,89/419,21.13%,CALM1;FGFR2;CALM2;CALM3;HSP90AB1;CTNNA3;HRAS;FGF1;GSK3B;RALA;JUN;KRAS;CYCS;CDC42;CTNNA1;ELOB;TGFB1;IFNGR2;NFE2L2;PTGER4;COL4A2;GNG7;GSTM6;PGF;HES1;TRAF6;RAC1;GSTO1;GSTM5;AKT3;PDGFRA;CCND3;MLH1;HSP90AA1;RHOA;RPS6KB2;FGF10;TGFA;RXRB;DVL1;PLCB1;RAD51;GNAS;CSF1R;AKT1;FGFR3;LAMC3;SMAD2;VEGFB;FZD1;CXCL12;TXNRD1;CASP8;LAMB1;BCL2;GADD45A;NFKB2;FADD;RELA;FOS;MAP2K1;GSTT2;JAG1;VEGFC;IL12RB2;TERT;CTBP2;FZD9;CAMK2B;CCNE2;FRAT1;CXCR4;LPAR1;ETS1;GNG3;MAPK3;FH1;LAMA5;MYC;IKBKG;DCC;FZD2;EGFR;FGF7;FZD3;FOXO1;CDKN1B;ITGAV;RAC3
gsea,Influenza A,-0.2636097226000954,-1.2043997951854404,0.13100436681222707,0.3065836093352846,1.0,21/105,17.23%,ACTB;HSPA2;GSK3B;VDAC1;JUN;ACTG1;HSPA8;CYCS;IVNS1ABP;IFNGR2;TNFRSF1A;AKT3;NXT2;ATF2;AKT1;TYK2;KPNA1;TLR3;RELA;MAP2K1;DNAJC3
gsea,T cell receptor signaling pathway,-0.28142306335893724,-1.1864858869707886,0.1868583162217659,0.3337664065468957,1.0,19/79,20.37%,HRAS;GSK3B;JUN;KRAS;NCK1;CDC42;PPP3R1;PPP3CA;AKT3;RHOA;MALT1;CD247;AKT1;RELA;FOS;MAP2K1;MAPK3;PTPRC;IKBKG
gsea,Insulin signaling pathway,0.2615418706874176,1.179526174672822,0.16731517509727625,0.9458098387112646,1.0,28/117,10.76%,MTOR;SORBS1;PHKA2;MAPK10;INSR;PYGL;ACACA;IKBKB;INPP5K;SHC1;PHKG2;SHC3;PIK3R2;GRB2;TSC1;PYGM;PHKA1;SOCS2;PIK3CD;AKT2;HKDC1;GYS1;PRKAR1B;EXOC7;PTPRF;PRKAG1;RPS6KB1;CBL
gsea,Fanconi anemia pathway,0.30780663437011935,1.1782422004817743,0.2088724584103512,0.8887258616334871,1.0,17/49,17.34%,ERCC4;FANCG;PMS2;ATR;EME2;BRIP1;TOP3B;POLH;BRCA2;POLK;FANCM;FANCC;REV3L;POLN;FANCD2;TOP3A;FANCI
gsea,RNA polymerase,-0.3524655995779618,-1.1779342212527497,0.22845691382765532,0.3461979915728386,1.0,10/26,23.45%,POLR3H;POLR2G;POLR1C;POLR3E;POLR1D;POLR2F;POLR3A;POLR3K;POLR2E;POLR3D
gsea,Inositol phosphate metabolism,0.28783546994027354,1.175044175574245,0.206,0.846808913687401,1.0,25/71,19.29%,PIKFYVE;PLCH1;PI4KA;INPP5K;SYNJ1;PIK3C2B;OCRL;PIK3CD;PI4K2B;INPP5B;INPP5J;MTM1;MTMR2;SYNJ2;PIK3CA;INPP4A;PIK3C2G;MTMR14;PIP5K1C;ITPKC;IPMK;PIP5K1A;PLCD3;INPP5A;PLCB4
gsea,Protein digestion and absorption,-0.29121548106811873,-1.1730901869508175,0.19444444444444445,0.35207579141954864,1.0,14/57,18.27%,ATP1B1;COL4A2;KCNJ13;ATP1A2;SLC16A10;COL6A1;ATP1B2;COL22A1;PRCP;SLC3A2;ATP1A1;SLC9A3;ATP1B3;COL9A2
gsea,p53 signaling pathway,-0.28373630160289365,-1.1698897002073385,0.20871559633027523,0.35530209479890573,1.0,31/60,39.77%,CYCS;RPRM;CCND3;RRM2B;CASP8;SHISA5;BCL2;GADD45A;ZMAT3;SIAH1B;CCNE2;SIVA1;STEAP3;BBC3;MDM4;DDB2;CCNB2;COP1;SIAH1A;CCND2;BAX;CDK4;PERP;IGFBP3;PPM1D;GADD45G;APAF1;CCNE1;IGF1;CCND1;CCNG1
gsea,Arrhythmogenic right ventricular cardiomyopathy (ARVC),-0.29390466575388385,-1.164638877823626,0.22268907563025211,0.361608256951398,1.0,18/64,26.22%,ACTB;CTNNA3;ACTG1;DSP;CTNNA1;ITGA8;GJA1;PKP2;CACNB3;CACNA1F;SGCB;EMD;ITGAV;ITGB1;ITGA7;JUP;ITGA10;ITGA4
gsea,Taste transduction,0.3258053971476533,1.155757245333889,0.2462962962962963,0.8739834433463404,1.0,11/37,17.31%,GABBR2;ASIC2;CACNA1A;SCN2A;ADCY8;GRM4;TAS1R1;ADCY6;CHRM3;CACNA1C;HTR1F
gsea,Amyotrophic lateral sclerosis (ALS),-0.29677496346492727,-1.1457668556690168,0.24385245901639344,0.3933990603096357,1.0,13/47,18.88%,NEFL;CYCS;NEFM;PPP3R1;PPP3CA;RAC1;TNFRSF1A;NEFH;SOD1;BCL2;RAB5A;GPX1;GRIA2
gsea,Cytokine-cytokine receptor interaction,-0.25498412303862805,-1.1428092798110843,0.21026894865525672,0.39603272844379783,1.0,34/113,28.10%,CX3CR1;TGFB1;IFNGR2;TNFRSF1A;INHBA;TNFRSF9;IL1RAP;BMPR1B;INHA;BMPR1A;CSF1R;IL16;CD27;CXCL12;CCL27A;IL1R2;IL12RB2;ACKR3;IL21R;BMP8B;CXCR4;IL17RB;CRLF2;TNFRSF12A;IL18;CNTFR;IL34;IL11RA1;CCL25;TNFSF12;IL4;CCR9;CX3CL1;ACKR4
gsea,Adrenergic signaling in cardiomyocytes,-0.2538267426497654,-1.1413290261434126,0.19866071428571427,0.39575671069860585,1.0,39/127,28.18%,CALM1;CALM2;ATP1B1;CALM3;PPP1R1A;PPP2R1A;ATP1A2;AKT3;ATP1B2;TPM1;PPP1CA;PPP2CA;ATF2;PLCB1;GNAS;ATF4;AKT1;ATP1A1;SCN1B;CACNB3;BCL2;CACNA1F;PIK3CG;ATP1B3;ATP2B1;CAMK2B;MAPK3;CREB3;PPP2R5B;FXYD2;CREB5;ADRA1D;ATP1A3;PLCB2;PRKACA;MYH7;PPP2R1B;ADCY9;TPM2
gsea,Toxoplasmosis,-0.2609718423754453,-1.1392891174250381,0.24162679425837322,0.39655076674506373,1.0,21/86,20.37%,HSPA2;HSPA8;CYCS;TGFB1;IFNGR2;TRAF6;TNFRSF1A;AKT3;LDLR;SOCS1;AKT1;TYK2;LAMC3;CASP8;LAMB1;BCL2;RELA;PIK3CG;MAPK3;LAMA5;IKBKG
gsea,TGF-beta signaling pathway,-0.27690965861134126,-1.1387374638810805,0.24892703862660945,0.3945704145657931,1.0,20/71,22.73%,TGFB1;PPP2R1A;FST;ID3;INHBA;RBL1;RHOA;RPS6KB2;BMPR1B;PPP2CA;CHRD;BMPR1A;SMAD7;SMAD2;ID2;BMP8B;MAPK3;MYC;LTBP1;E2F4
gsea,Human T-cell leukemia virus 1 infection,-0.238248759061289,-1.137913765326986,0.19036697247706422,0.3930401058812669,1.0,41/171,20.96%,SLC25A4;SLC25A5;HRAS;VDAC1;JUN;RAN;CALR;KRAS;CANX;VDAC3;TGFB1;POLB;ETS2;PPP3R1;PPP3CA;GPS2;TNFRSF1A;AKT3;CCND3;VDAC2;B2M;ATF2;ATF4;AKT1;BUB3;RANBP1;SMAD2;IL1R2;NFKB2;RELA;FOS;MAP2K1;H2-T22;TERT;CCNE2;ETS1;MAPK3;MYC;IKBKG;CREB3;H2-T24
gsea,Serotonergic synapse,-0.25099948528874594,-1.134070418972643,0.19912472647702406,0.3963977369007023,1.0,27/95,27.45%,HRAS;KRAS;HTR2B;KCNJ3;GNG7;PTGS1;HTR4;GABRB3;PLCB1;GNAS;KCND2;CACNA1F;MAP2K1;HTR5A;GABRB2;GNG3;MAPK3;SLC18A2;GNB2;HTR3A;DUSP1;KCNN2;ITPR2;PLCB2;GNG10;PRKACA;ALOX5
gsea,Tight junction,-0.2520022605843986,-1.133715696559403,0.2268041237113402,0.39412267864454326,1.0,40/124,30.23%,ACTB;TUBA1A;JUN;ACTG1;MYL6;PARD6A;TUBA4A;CDC42;PPP2R1A;RAC1;WASL;TUBA1B;PCNA;RHOA;ACTR3;PPP2CA;MYL9;ACTR2;CLDN5;PARD6G;STK11;WHAMM;MYL12A;HSPA4;MYH14;CTTN;RAB8B;ITGB1;ACTR3B;TIAM1;PRKACA;PPP2R1B;DLG1;RAB13;MSN;PRKCI;DLG2;MYL12B;CDK4;CLDN18
gsea,Cortisol synthesis and secretion,-0.28935474779134196,-1.1315655396991084,0.2692307692307692,0.3952372850374945,1.0,22/54,31.65%,STAR;NCEH1;LDLR;KCNK2;ATF2;PLCB1;GNAS;ATF4;NR4A1;POMC;CACNA1F;CREB3;HSD3B6;ITPR2;CREB5;PLCB2;PRKACA;ADCY9;PBX1;CREB3L1;GNA11;AGT
gsea,HIF-1 signaling pathway,-0.25358839200970956,-1.1312039485713752,0.23306772908366533,0.3928248050869941,1.0,23/90,21.09%,GAPDH;ALDOA;ANGPT2;ENO2;TEK;ELOB;IFNGR2;AKT3;RPS6KB2;RPS6;AKT1;TRF;PGK1;TFRC;BCL2;RELA;MAP2K1;PFKL;CAMK2B;MAPK3;EGFR;ENO4;CDKN1B
gsea,Fc gamma R-mediated phagocytosis,-0.2754280101508174,-1.1257887725840934,0.25609756097560976,0.4010448051977472,1.0,22/81,20.68%,CFL1;ARPC3;ARPC1B;LYN;CDC42;ARPC2;RAC1;WASL;AKT3;ARPC5;CFL2;RPS6KB2;NCF1;AKT1;DOCK2;MYO10;MAP2K1;ARPC5L;WASF1;MAPK3;PTPRC;INPPL1
gsea,Adherens junction,-0.2823442431411083,-1.1226184216672754,0.2725490196078431,0.4043277255883747,1.0,18/66,22.37%,ACTB;CTNNA3;ACP1;ACTG1;YES1;CDC42;CTNNA1;RAC1;WASL;RHOA;SMAD2;CSNK2B;BAIAP2;WASF1;MAPK3;EGFR;RAC3;PTPN1
gsea,Dopaminergic synapse,-0.25001662102361083,-1.1149109306312395,0.2717842323651452,0.4160959649575197,1.0,17/115,12.69%,CALM1;CALM2;CALM3;CALY;GSK3B;KCNJ3;GNG7;PPP2R1A;PPP3CA;AKT3;PPP1CA;PPP2CA;ATF2;PLCB1;GNAS;ATF4;AKT1
gsea,"Glycine, serine and threonine metabolism",-0.3108983587102132,-1.1114486464055333,0.28537735849056606,0.4197935651324893,1.0,8/32,16.68%,PGAM1;CHDH;PHGDH;PGAM2;PSAT1;BPGM;PIPOX;GLYCTK
gsea,Mismatch repair,-0.34252978398881256,-1.1113638522340636,0.31497797356828194,0.41702611106832016,1.0,8/22,32.76%,POLD4;PCNA;MLH1;SSBP1;MSH2;EXO1;RFC5;POLD2
gsea,Arachidonic acid metabolism,-0.2950251088005814,-1.1018986062044935,0.2853598014888337,0.4326181045262135,1.0,9/39,17.04%,HPGDS;PTGS1;PLA2G3;PTGES3;PTGIS;GPX8;CBR1;PTGDS;GPX1
gsea,Purine metabolism,-0.23630851388777363,-1.0997842206854178,0.2600896860986547,0.4336608110497693,1.0,46/116,35.03%,NME2;NME7;HPRT;NUDT5;PAPSS2;PKM;PDE3B;NME4;AK6;NME1;FHIT;DGUOK;NUDT16;RRM2B;AK1;PDE7A;APRT;PDE3A;PRPS1;ENTPD1;PDE7B;NUDT9;ADK;PRPS1L3;DCK;PAICS;IMPDH1;AK7;AK9;GMPR;CANT1;ADCY9;ADSSL1;PNP;GUCY1B1;GDA;PDE6B;NUDT2;ENTPD2;ENPP1;ADCY10;NTPCR;ADPRM;HDDC3;NT5C1A;GUCY2E
gsea,Vascular smooth muscle contraction,-0.2528523233374366,-1.099029152844237,0.26948775055679286,0.4322796513353395,1.0,17/95,17.14%,CALM1;CALM2;CALM3;MYL6;RAMP1;ACTA2;PLA2G3;RHOA;PPP1CA;PLCB1;GNAS;MYL9;PRKG1;CALD1;CACNA1F;MAP2K1;CALCB
gsea,Morphine addiction,0.2655772523906997,1.097660041264849,0.3182711198428291,1.0,1.0,26/79,20.63%,GABBR2;CACNA1B;CACNA1A;GABRG3;ADCY8;PRKCG;PDE2A;GRK3;PDE10A;GRK4;PRKCB;PRKCA;PDE11A;ADCY1;GRK5;PDE8A;GRK2;ADCY6;GNB5;DRD1;ARRB1;ADCY3;ADCY2;ADCY7;GABRR3;ADCY5
gsea,JAK-STAT signaling pathway,0.25089370569919517,1.092871258659748,0.3093145869947276,1.0,1.0,22/100,13.68%,MTOR;SOCS7;STAT1;EP300;CREBBP;PIK3R2;GRB2;IL20RB;STAT2;SOCS2;PIK3CD;AKT2;PTPN2;PIAS4;FHL1;JAK3;JAK2;IFNAR1;PRLR;IL4RA;STAT5B;PIK3CA
gsea,Sphingolipid metabolism,0.28941232528979843,1.0928213060218688,0.30426356589147285,0.9964696562650686,1.0,8/42,10.88%,CERS4;CERS1;SMPD3;CERK;NEU2;ASAH1;CERS5;SPTLC2
gsea,ErbB signaling pathway,0.2661645476525328,1.0915178724173267,0.310838445807771,0.9543277667890191,1.0,22/79,14.47%,MTOR;MAPK10;NRG1;PRKCG;SHC1;PTK2;SHC3;PIK3R2;GRB2;PRKCB;CAMK2D;PAK3;PRKCA;PIK3CD;AKT2;RPS6KB1;CBL;CAMK2A;CRKL;STAT5B;PIK3CA;CRK
gsea,mRNA surveillance pathway,0.2547483687614589,1.0904583111185577,0.2917505030181087,0.9150807517205534,1.0,20/83,13.37%,SRRM1;SMG1;CPSF3;MSI2;CSTF2;PABPN1;SMG7;ACIN1;PAPOLB;CPSF7;NXF1;PNN;HBS1L;PPP2R5C;PPP2R2C;PAPOLG;CASC3;UPF3B;PAPOLA;PABPC5
gsea,Leishmaniasis,-0.2835654953122954,-1.0880523279538614,0.3014018691588785,0.45077697758607405,1.0,19/43,35.17%,JUN;TGFB1;IFNGR2;TRAF6;CYBA;NCF1;RELA;FOS;MAPK3;ITGAM;TLR4;ITGB1;ITGA4;IL4;ELK1;NFKBIB;FCGR3;MAPK12;IRAK4
gsea,Calcium signaling pathway,-0.23754606432255118,-1.0840401165818818,0.2882882882882883,0.45577798022347527,1.0,19/155,9.66%,CALM1;CALM2;SLC25A4;SLC25A5;CALM3;VDAC1;HTR2B;VDAC3;ORAI3;PPP3R1;STIM2;PPP3CA;PTK2B;ORAI2;HTR4;GRM1;PDGFRA;CAMK1;VDAC2
gsea,cAMP signaling pathway,-0.2324376485398682,-1.0827195539536274,0.29545454545454547,0.45534835332610923,1.0,39/169,21.13%,CALM1;CALM2;ATP1B1;CALM3;JUN;GABBR1;NPY;BDNF;RAC1;ATP1A2;PDE3B;HTR4;AKT3;SSTR2;ATP1B2;RHOA;PPP1CA;GNAS;AKT1;MYL9;ATP1A1;FXYD1;PDE3A;POMC;CACNA1F;RELA;FOS;MAP2K1;PPARA;PPP1R1B;ATP1B3;GRIA2;ATP2B1;CAMK2B;VIP;MAPK3;ACOX1;CREB3;RAC3
gsea,One carbon pool by folate,0.354824059908073,1.0809951260744097,0.348747591522158,0.9118350000449248,1.0,5/18,13.87%,MTFMT;AMT;MTHFD1L;MTR;SHMT2
gsea,Bladder cancer,-0.3015680569599776,-1.0742453299610517,0.3304535637149028,0.4696581243604274,1.0,7/33,20.62%,HRAS;KRAS;FGFR3;MAP2K1;MAPK3;MYC;EGFR
gsea,Herpes simplex virus 1 infection,0.20916027136612417,1.0738058561086945,0.26017699115044246,0.9005017106381025,1.0,71/323,16.83%,SRSF5;MTOR;SRSF1;STAT1;GM14391;CHUK;ZFP90;ZFP933;IKBKB;POU2F2;ZFP282;GM14393;ZFP950;PIK3R2;ZFP157;TSC1;ZFP647;ZFP7;STAT2;ZFP12;ZFP52;ZFP788;ZFP715;NXF1;ZFP975;ZFP473;ZFP677;PIK3CD;AKT2;ZFP68;ZFP760;GM14308;ZFP458;EIF2AK1;ZFP712;ZFP354B;GM14326;EIF2AK3;ZFP810;ZFP708;ZFP568;ZFP53;ZFP994;ZFP874A;JAK2;ZFP317;ZFP982;IFNAR1;TAB1;MAP3K7;ZFP956;H2-M5;EIF2AK4;TAPBP;PIK3CA;ZFP747;SRSF6;ZFP128;ZFP229;ZFP354C;SRSF4;GM3055;ZFP251;ZFP944;ZFP790;ZFP961;ZFP946;ZFP626;ZFP33B;HCFC2;ZFP426
gsea,Thyroid cancer,-0.2958582102677356,-1.0725085242648265,0.344017094017094,0.4698836940614649,1.0,12/34,31.11%,HRAS;KRAS;RXRB;GADD45A;MAP2K1;MAPK3;MYC;RXRG;DDB2;BAX;PPARG;MAP2K2
gsea,Fructose and mannose metabolism,-0.3082319130986144,-1.063987116584055,0.35639412997903563,0.48417522759499126,1.0,11/28,28.60%,ALDOA;TPI1;ALDOC;PMM1;GMDS;PFKL;PFKFB1;AKR1B10;SORD;PFKFB4;HK2
gsea,Leukocyte transendothelial migration,-0.25567363152906375,-1.0559679930124204,0.3582089552238806,0.49735962412385426,1.0,15/81,15.55%,ACTB;CTNNA3;ACTG1;CDC42;CTNNA1;THY1;PTK2B;RAC1;RHOA;CYBA;NCF1;MYL9;CXCL12;BCAR1;CLDN5
gsea,Cushing syndrome,-0.23111896945889362,-1.054515293911545,0.3286384976525822,0.49678667926932474,1.0,47/127,32.98%,GSK3B;STAR;NCEH1;LDLR;KCNK2;DVL1;ATF2;PLCB1;GNAS;ATF4;NR4A1;ARMC5;FZD1;POMC;CACNA1F;MAP2K1;RBBP5;FZD9;CAMK2B;CCNE2;MAPK3;FH1;FZD2;EGFR;CREB3;FZD3;CDKN1B;HSD3B6;ITPR2;AIP;WNT2B;CREB5;PLCB2;PRKACA;ASH2L;AXIN2;ADCY9;ARNT;PBX1;CDK4;CREB3L1;GNA11;MAP2K2;GNAI1;AGT;FZD8;CRHR2
gsea,Prolactin signaling pathway,0.26480719194522023,1.050803305005703,0.3730769230769231,0.9519363504856374,1.0,15/58,13.68%,SOCS7;MAPK10;STAT1;SHC1;SHC3;PIK3R2;GRB2;SOCS2;PIK3CD;AKT2;MAPK14;JAK2;PRLR;STAT5B;PIK3CA
gsea,Hepatocellular carcinoma,-0.219408001415736,-1.0379013303545974,0.3431578947368421,0.5293587363232081,1.0,30/144,21.03%,ACTB;HRAS;GSK3B;ACTG1;KRAS;TGFB1;NFE2L2;GSTM6;GSTO1;GSTM5;AKT3;RPS6KB2;TGFA;DVL1;AKT1;SMAD2;FZD1;TXNRD1;GADD45A;MAP2K1;GSTT2;TERT;FZD9;FRAT1;MAPK3;MYC;SMARCB1;FZD2;EGFR;FZD3
gsea,Nicotinate and nicotinamide metabolism,-0.3025726238964399,-1.0359844381107148,0.3875802997858672,0.5298527637196757,1.0,17/26,44.72%,CD38;NADSYN1;PNP;ENPP1;NNMT;NMRK1;NT5C1A;ASPDH;AOX1;NMNAT1;NNT;NADK;ENPP3;NMNAT3;AOX4;NT5C;NT5M
gsea,Progesterone-mediated oocyte maturation,0.2463567859234708,1.032818226910192,0.38336713995943206,0.9873768684990011,1.0,27/75,20.82%,MAPK10;ANAPC1;ADCY8;RPS6KA2;ANAPC5;CDC25B;PIK3R2;PGR;MAD1L1;PIK3CD;AKT2;CPEB3;CDC23;MAPK14;ADCY1;ANAPC11;RPS6KA6;CDC27;PIK3CA;CPEB1;ADCY6;MAPK8;ADCY3;ADCY2;ADCY7;ADCY5;CDC25A
gsea,Aldosterone-regulated sodium reabsorption,-0.2954230406719021,-1.0279538041119913,0.40755467196819084,0.5437740261740879,1.0,8/29,19.98%,ATP1B1;KRAS;ATP1A2;ATP1B2;NR3C2;ATP1A1;ATP1B3;MAPK3
gsea,VEGF signaling pathway,-0.2616710502864934,-1.022122826432288,0.398422090729783,0.5531223212488787,1.0,7/50,7.82%,HRAS;KRAS;CDC42;PPP3R1;PPP3CA;RAC1;AKT3
gsea,Lysosome,-0.22759904775887363,-1.0139506112320245,0.4158415841584158,0.5674832176988843,1.0,38/111,29.67%,ATP6V0B;ATP6V0C;LAPTM4A;CLTB;CLTA;CTSB;FUCA1;CTSZ;AP1S1;HYAL1;CTSC;AP1S3;GM2A;CD63;CTSL;AGA;GNPTG;SGSH;GNS;CTSS;SCARB2;AP1S2;PLA2G15;TPP1;LAMP1;AP1M1;CTSO;NAGPA;CTSF;CLN5;ARSB;MAN2B1;CTSH;M6PR;AP3S2;SLC11A2;CTSD;PSAP
gsea,AGE-RAGE signaling pathway in diabetic complications,-0.2369353565034257,-1.012681712930415,0.3912133891213389,0.5666297573848409,1.0,19/82,21.09%,HRAS;JUN;KRAS;CDC42;TGFB1;COL4A2;RAC1;AKT3;PLCB1;AKT1;SMAD2;F3;VEGFB;BCL2;RELA;VEGFC;MAPK3;FOXO1;CDKN1B
gsea,MicroRNAs in cancer,0.22729221890257242,1.0124352046661196,0.43486238532110094,1.0,1.0,42/125,23.23%,MTOR;EP300;IKBKB;PRKCG;CREBBP;SHC1;ATM;DICER1;APC2;CDC25B;GRB2;PRKCB;MDM2;DNMT3A;PRKCE;ROCK1;MET;PRKCA;ZEB1;MMP16;CD44;APC;CRKL;CRK;E2F2;HMGA2;DNMT1;TGFB2;TRIM71;HNRNPK;SOS2;MMP9;RPTOR;RPS6KA5;CDC25A;TNC;PLCG1;NFKB1;THBS1;ZEB2;EZR;ABCC1
gsea,Hedgehog signaling pathway,0.2827281958961435,1.011932432372518,0.40077821011673154,0.9932394532518525,1.0,13/40,22.00%,SMURF1;SUFU;SMURF2;CSNK1A1;GRK3;KIF3A;GRK2;LRP2;EVC2;CSNK1E;ARRB1;PTCH1;CSNK1D
gsea,Cell cycle,-0.2221902290909267,-1.0110175704218634,0.4206896551724138,0.5668108344212539,1.0,18/110,14.04%,YWHAG;GSK3B;YWHAE;YWHAB;TGFB1;ANAPC13;YWHAH;ORC1;STAG1;RBL1;PCNA;CCND3;YWHAZ;MCM2;BUB3;SMAD2;ORC4;CDKN2D
gsea,Primary immunodeficiency,-0.3463877769236603,-1.0081301763667079,0.4583333333333333,0.569756677454843,1.0,5/15,23.91%,BTK;RFXAP;PTPRC;IKBKG;BLNK
gsea,Platelet activation,-0.23122472051774684,-1.0053389333299083,0.43555555555555553,0.5725949318339367,1.0,31/101,30.11%,ACTB;P2RY12;ACTG1;LYN;BTK;PTGS1;AKT3;RHOA;PPP1CA;P2RY1;PLCB1;GNAS;AKT1;PRKG1;PIK3CG;FERMT3;MAPK3;MYL12A;MYLK3;ITPR2;ITGB1;NOS3;TLN1;PLCB2;PRKACA;ADCY9;ARHGEF1;PRKCI;GUCY1B1;MYL12B;PPP1CC
gsea,MAPK signaling pathway,-0.20210063786196872,-1.0043444242086397,0.4393939393939394,0.5712185500102139,1.0,53/249,21.13%,FGFR2;HRAS;HSPA2;FGF1;JUN;KRAS;ANGPT2;LAMTOR3;HSPA8;TEK;CDC42;TGFB1;PPP3R1;PGF;TRAF6;BDNF;PPP3CA;JUND;RAC1;TNFRSF1A;AKT3;PDGFRA;RASA1;FGF10;TGFA;IL1RAP;ATF2;CSF1R;ATF4;MAPK8IP1;AKT1;FGFR3;NR4A1;VEGFB;PDGFC;CACNB3;GADD45A;CACNA1F;NFKB2;RELA;FOS;MAP2K1;VEGFC;DUSP6;DUSP4;MAPK3;STMN1;MYC;IKBKG;EGFR;FGF7;ECSIT;RAC3
gsea,Circadian rhythm,0.3083780367778279,1.0029501731742079,0.4481409001956947,0.9922623416541367,1.0,13/27,26.27%,NPAS2;CRY2;RORA;PRKAG1;PRKAA2;FBXL3;CSNK1E;PRKAG2;PER3;CSNK1D;CREB1;PER1;PER2
gsea,Relaxin signaling pathway,-0.22176531130528904,-0.9987038281983784,0.4531914893617021,0.5802530945024975,1.0,26/108,21.89%,HRAS;JUN;KRAS;TGFB1;COL4A2;GNG7;ACTA2;AKT3;RXFP3;ATF2;PLCB1;GNAS;ATF4;AKT1;SMAD2;VEGFB;RELA;FOS;MAP2K1;VEGFC;GNG3;MAPK3;EGFR;GNA15;CREB3;GNB2
gsea,Breast cancer,-0.21374441946912293,-0.997708264182647,0.44930875576036866,0.5791740874924217,1.0,25/120,21.03%,HRAS;FGF1;GSK3B;JUN;KRAS;HES1;AKT3;RPS6KB2;FGF10;DVL1;AKT1;FZD1;GADD45A;NFKB2;FOS;MAP2K1;JAG1;FZD9;FRAT1;MAPK3;MYC;FZD2;EGFR;FGF7;FZD3
gsea,Thyroid hormone signaling pathway,0.22534627184152625,0.9949883457652217,0.4678362573099415,0.9884101398360543,1.0,25/111,11.78%,MTOR;MED13;MED24;STAT1;EP300;NCOA3;PRKCG;MED13L;CREBBP;PIK3R2;PRKCB;NCOR1;MED27;NCOA1;MDM2;PRKCA;PIK3CD;AKT2;BMP4;HDAC3;RXRA;MED12L;MED12;PFKFB2;WNT4
gsea,Hepatitis B,-0.21564598972501542,-0.99446837379596,0.4409090909090909,0.5830396409563726,1.0,31/132,21.20%,HRAS;JUN;KRAS;YWHAB;CYCS;VDAC3;TGFB1;TRAF6;PTK2B;AKT3;PCNA;ATF2;YWHAZ;ATF4;AKT1;TYK2;SMAD2;CASP8;TLR3;BCL2;FADD;RELA;FOS;MAP2K1;CCNE2;MAPK3;MYC;IKBKG;SLC10A1;CREB3;MAVS
gsea,Inflammatory mediator regulation of TRP channels,-0.23331299013124387,-0.9942583293930889,0.46170212765957447,0.5799570067150749,1.0,9/80,11.60%,CALM1;CALM2;CALM3;HTR2B;PTGER4;IL1RAP;PPP1CA;PLCB1;GNAS
gsea,Pentose phosphate pathway,-0.2984697756326551,-0.9930374518187111,0.444672131147541,0.5792208346595965,1.0,7/24,19.27%,ALDOA;ALDOC;PRPS1;GLYCTK;PFKL;IDNK;PRPS1L3
gsea,Renal cell carcinoma,-0.23631001969607754,-0.9800922533155898,0.5079681274900398,0.6048480717068521,1.0,9/67,9.87%,HRAS;JUN;KRAS;CDC42;ELOB;TGFB1;RAC1;AKT3;TGFA
gsea,Measles,-0.21973063004370974,-0.9736754564821639,0.5043290043290043,0.61586305168297,1.0,31/95,30.30%,HSPA2;GSK3B;JUN;HSPA8;CYCS;RACK1;TRAF6;AKT3;CCND3;AKT1;TYK2;CSNK2B;CASP8;BCL2;FADD;RELA;FOS;CCNE2;IKBKG;CDKN1B;MAVS;BBC3;TLR4;CCND2;BAX;MSN;FCGR2B;TRADD;TLR7;CDK4;BAD
gsea,Ovarian steroidogenesis,0.2710790312577328,0.9710081025742163,0.48841354723707664,1.0,1.0,13/36,20.63%,INSR;ADCY8;CYP2J6;CYP2J8;ADCY1;CYP2J12;PLA2G4E;ADCY6;PLA2G4A;ADCY3;ADCY2;ADCY7;ADCY5
gsea,Pancreatic secretion,-0.24098921872769796,-0.9563165651507034,0.5303983228511531,0.6524553956995196,1.0,21/61,28.93%,ATP1B1;RAB11A;PLA2G3;RAC1;ATP1A2;ATP1B2;RHOA;PLCB1;GNAS;ATP1A1;CCK;CD38;ATP1B3;ATP2B1;ITPR2;FXYD2;CAR2;ATP1A3;PLCB2;ADCY9;RAB27B
gsea,"Valine, leucine and isoleucine degradation",0.24717914293053717,0.9514887928836466,0.524904214559387,1.0,1.0,15/46,27.30%,MCCC1;BCKDHB;PCCA;AACS;ACSF3;BCAT2;HADHB;IVD;DLD;ACADSB;ACADM;HSD17B10;ACADS;ALDH1B1;PCCB
gsea,Linoleic acid metabolism,0.343694323009218,0.9486260111941435,0.5257352941176471,1.0,1.0,7/15,25.34%,CYP2J6;CYP2J8;CYP2J12;PLA2G4E;PLA2G4A;CYP2C55;CYP2C65
gsea,Aminoacyl-tRNA biosynthesis,0.25395939771592135,0.9456861609642601,0.545816733067729,1.0,1.0,14/42,22.72%,LARS2;MTFMT;HARS;VARS;EARS2;GARS;PARS2;HARS2;TARS;CARS;FARSA;YARS;DARS;DARS2
gsea,Circadian entrainment,0.23599383472213575,0.9448109625988248,0.532319391634981,1.0,1.0,30/85,20.83%,GUCY1A2;GRIN1;GRIA4;CACNA1I;NOS1;ADCY8;PRKCG;RYR2;PRKCB;CAMK2D;PRKCA;ADCY1;CAMK2A;NOS1AP;GRIN2D;ADCYAP1R1;RYR3;ADCY6;CACNA1H;CACNA1C;GNB5;PLCB4;ADCY3;CACNA1G;ADCY2;ADCY7;GRIA3;RPS6KA5;ADCY5;PER3
gsea,TNF signaling pathway,-0.22025621211707042,-0.944808894027487,0.5309168443496801,0.6754869489966517,1.0,19/82,20.93%,JUN;JUNB;BAG4;CEBPB;TNFRSF1A;AKT3;ATF2;ATF4;AKT1;CASP8;FADD;RELA;FOS;MAP2K1;JAG1;MAPK3;IKBKG;IRF1;CREB3
gsea,Th17 cell differentiation,-0.22792768171898956,-0.9376294102634942,0.5479744136460555,0.6884400788615612,1.0,17/68,20.37%,HSP90AB1;JUN;TGFB1;IFNGR2;PPP3R1;PPP3CA;HSP90AA1;IL1RAP;RXRB;CD247;TYK2;SMAD2;RELA;FOS;IL21R;MAPK3;IKBKG
gsea,Porphyrin and chlorophyll metabolism,-0.2888045244766028,-0.9313188392479783,0.5756972111553785,0.6989574022559017,1.0,11/21,43.67%,HMOX2;FECH;MMAB;ALAD;HMBS;UROS;BLVRB;HCCS;FXN;COX15;COX10
gsea,Chemokine signaling pathway,-0.20626522539823616,-0.9307592660417613,0.5958762886597938,0.6961887466001561,1.0,38/127,27.74%,HRAS;GSK3B;KRAS;CX3CR1;LYN;CDC42;GNG7;PTK2B;RAC1;WASL;AKT3;RHOA;NCF1;PLCB1;AKT1;CXCL12;DOCK2;CCL27A;BCAR1;RELA;MAP2K1;PIK3CG;CXCR4;GNG3;MAPK3;IKBKG;RAC3;GNB2;PXN;CCL25;TIAM1;PLCB2;GNG10;PRKACA;CCR9;CX3CL1;FOXO3;ADCY9
gsea,Fat digestion and absorption,-0.31488851453279987,-0.9270028490975292,0.549800796812749,0.7012419423808852,1.0,5/16,26.91%,APOA1;PLA2G3;DGAT2;PLPP1;PLPP3
gsea,Neuroactive ligand-receptor interaction,-0.1905412130527727,-0.9259488668274147,0.6575682382133995,0.6997766309789725,1.0,32/190,19.82%,GLP2R;P2RY14;HTR2B;GABBR1;MAS1;GRIK2;PTGER4;NTSR2;NPY;GLRB;HTR4;S1PR3;GRM1;NMUR1;SSTR2;GABRB3;CORT;P2RY1;RXFP3;GABRG2;CHRNA7;GRP;CCK;POMC;CALCB;NPFFR1;PENK;HTR5A;GRIA2;GABRB2;VIP;LPAR1
gsea,beta-Alanine metabolism,-0.2701469430407872,-0.9235184671460516,0.5822510822510822,0.7017192062347265,1.0,11/26,39.48%,SMS;CNDP2;SRM;HIBCH;MLYCD;DPYS;DPYD;ABAT;AOC2;ECHS1;ALDH2
gsea,Axon guidance,-0.1975006134980908,-0.9202935944621409,0.5991902834008097,0.7049009330323749,1.0,21/169,10.30%,HRAS;CFL1;GSK3B;LRRC4;KRAS;NCK1;EPHA7;PARD6A;CDC42;PPP3R1;PPP3CA;RAC1;DPYSL2;SEMA5A;CFL2;UNC5D;ROBO1;RHOA;RASA1;TRPC4;BMPR1B
gsea,Focal adhesion,-0.19516100407208054,-0.9124521535385827,0.6600441501103753,0.719305799199818,1.0,53/173,30.30%,ACTB;HRAS;GSK3B;JUN;ACTG1;CDC42;COL4A2;ITGA8;PGF;RAC1;AKT3;COL6A1;PDGFRA;CCND3;RHOA;PPP1CA;AKT1;MYL9;CAV2;LAMC3;VEGFB;PDGFC;LAMB1;BCAR1;BCL2;MAP2K1;THBS3;VEGFC;DOCK1;COL9A2;MAPK3;LAMA5;EGFR;ITGAV;RAC3;MYL12A;MYLK3;PXN;ITGB1;ITGA7;PAK2;ITGA10;ITGA4;TLN1;CCND2;ELK1;VCL;FLT1;ITGB5;MYL12B;LAMB3;PPP1CC;BAD
gsea,Acute myeloid leukemia,0.23380599551248324,0.9096953884146881,0.6053130929791272,1.0,1.0,14/59,14.16%,MTOR;CHUK;IKBKB;FLT3;PIK3R2;GRB2;PIK3CD;AKT2;RUNX1T1;RPS6KB1;STAT5B;PIK3CA;ZBTB16;PPARD
gsea,Fc epsilon RI signaling pathway,-0.22829183031738537,-0.9061948108873629,0.604602510460251,0.7296731393911333,1.0,6/55,7.82%,HRAS;KRAS;LYN;BTK;RAC1;AKT3
gsea,Pancreatic cancer,-0.21688034227143468,-0.9055388915498165,0.6288659793814433,0.726976302344091,1.0,18/72,21.13%,RALA;KRAS;CDC42;TGFB1;RAC1;AKT3;RPS6KB2;TGFA;RAD51;AKT1;SMAD2;GADD45A;RELA;MAP2K1;MAPK3;IKBKG;EGFR;RAC3
gsea,Glycosphingolipid biosynthesis,0.2546364616770367,0.9013690147035321,0.605683836589698,1.0,1.0,4/37,4.83%,HEXB;ST3GAL3;ST6GALNAC5;SEC1
gsea,Regulation of lipolysis in adipocytes,0.24208671495510586,0.9012070490504576,0.6166982922201139,1.0,1.0,15/43,20.91%,PTGER3;INSR;ADCY8;PIK3R2;PIK3CD;AKT2;ADCY1;PIK3CA;ADCY6;TSHR;ADCY3;ADCY2;ADCY7;ADCY5;MGLL
gsea,GABAergic synapse,-0.2193270909354848,-0.8999197643955518,0.6178217821782178,0.7357300643467891,1.0,14/74,15.68%,GABARAPL1;GABBR1;GABARAP;GABARAPL2;GNG7;PLCL1;GLUL;GABRB3;NSF;SLC32A1;GABRG2;SLC38A3;GPHN;CACNA1F
gsea,Amoebiasis,-0.2198716340580228,-0.8982121860624825,0.6535087719298246,0.7355180443064598,1.0,22/62,30.19%,TGFB1;RAB5B;COL4A2;PLCB1;GNAS;LAMC3;LAMB1;IL1R2;RELA;RAB5A;RAB7;LAMA5;GNA15;ITGAM;TLR4;SERPINB6A;PLCB2;PRKACA;VCL;LAMB3;ARG2;GNA11
gsea,Transcriptional misregulation in cancer,0.20501879190358852,0.8979001826476091,0.6541889483065954,1.0,1.0,31/125,16.54%,FUS;ARNT2;PRCC;TFE3;FLT3;ATM;PTK2;MLLT1;ETV6;NCOR1;MDM2;MET;SIX4;CDK9;ZEB1;RUNX1T1;POLK;RXRA;RUNX2;CCNT2;CDK14;NSD2;BAIAP3;ZBTB16;MEIS1;TAF15;NFKBIZ;HMGA2;KMT2A;MAX;DOT1L
gsea,Sphingolipid signaling pathway,0.2020784810221551,0.8966257426569298,0.6627218934911243,1.0,1.0,31/107,19.72%,CERS4;MAPK10;CERS1;PRKCG;PIK3R2;PRKCB;MAP3K5;PLD2;ASAH1;PRKCE;ROCK1;PRKCA;PIK3CD;AKT2;PPP2R5C;PPP2R2C;CERS5;MAPK14;SPTLC2;ROCK2;PIK3CA;PRKCZ;FYN;MAPK8;CERS6;PLD1;PPP2R3C;PPP2R2D;PPP2R3D;PLCB4;SGMS2
gsea,Amino sugar and nucleotide sugar metabolism,0.23792266911369725,0.8939191007217013,0.6399253731343284,1.0,1.0,7/44,12.72%,HEXB;GPI1;GALE;HKDC1;UGDH;PMM2;PGM2
gsea,RIG-I-like receptor signaling pathway,0.24379411701744239,0.8753172035444876,0.660377358490566,1.0,1.0,10/40,18.54%,MAPK10;CHUK;IKBKB;AZI2;SIKE1;MAPK14;MAP3K7;OTUD5;MAPK8;NLRX1
gsea,Chronic myeloid leukemia,0.21406048342127298,0.8730652370110087,0.6679462571976967,1.0,1.0,17/73,14.52%,CHUK;IKBKB;SHC1;SHC3;PIK3R2;GRB2;MDM2;PIK3CD;AKT2;POLK;CBL;CRKL;STAT5B;BCR;PIK3CA;CRK;E2F2
gsea,Proteoglycans in cancer,0.1909640761142505,0.8724974404519001,0.7587476979742173,1.0,1.0,33/164,13.68%,MTOR;FLNB;ANK3;IQGAP1;FLNA;PRKCG;ANK1;PTK2;PIK3R2;GRB2;PRKCB;SDC2;MDM2;CAMK2D;ROCK1;MET;PRKCA;PIK3CD;AKT2;MAPK14;DCN;DROSHA;HPSE;RPS6KB1;CBL;CD44;WNT4;COL1A2;ANK2;CAMK2A;ROCK2;RRAS2;PIK3CA
gsea,Th1 and Th2 cell differentiation,0.21992264276773266,0.870305252851654,0.702247191011236,0.9925344232432475,1.0,14/58,13.61%,MAPK10;STAT1;CHUK;IKBKB;PPP3R2;PPP3CB;JAK3;MAPK14;NFKBIE;JAK2;PPP3CC;JAG2;IL4RA;STAT5B
gsea,Natural killer cell mediated cytotoxicity,-0.21244462494741886,-0.8696188336889831,0.6936170212765957,0.7965258477984452,1.0,7/66,7.13%,HRAS;KRAS;IFNGR2;PPP3R1;PPP3CA;PTK2B;RAC1
gsea,Adipocytokine signaling pathway,-0.21638976339049876,-0.8665959667146392,0.7223427331887202,0.7985262500460468,1.0,14/58,20.37%,CPT1C;NPY;ACSL3;TNFRSF1A;AKT3;AGRP;IRS2;RXRB;AKT1;POMC;RELA;PPARA;STK11;IKBKG
gsea,"Alanine, aspartate and glutamate metabolism",-0.24319397803017923,-0.8653987767708632,0.6666666666666666,0.7969465267470351,1.0,12/32,36.85%,GLUL;NAT8L;ALDH5A1;ASNS;ADSSL1;GFPT2;GFPT1;GOT1;CAD;ABAT;NIT2;GLS
gsea,Mannose type O-glycan biosynthesis,-0.26546853107585,-0.8637359664173926,0.6375,0.7963142869211103,1.0,8/21,30.70%,B4GAT1;FKRP;B3GAT1;LARGE2;FKTN;POMT2;B4GALT3;B4GALT1
gsea,Type I diabetes mellitus,0.29589029585221727,0.863330274628863,0.6444866920152091,0.9891012336361267,1.0,3/17,12.97%,PTPRN2;ICA1;H2-M5
gsea,FoxO signaling pathway,-0.19217533192579672,-0.8616147618739576,0.7569296375266524,0.7968824719779589,1.0,23/110,21.09%,HRAS;GABARAPL1;KRAS;GABARAP;TGFB1;GABARAPL2;AKT3;IRS2;GRM1;SETD7;HOMER1;AKT1;SMAD2;CDKN2D;GADD45A;MAP2K1;STK11;ATG12;MAPK3;EGFR;FOXO4;FOXO1;CDKN1B
gsea,Glycerophospholipid metabolism,0.1991762053768324,0.8596444497516081,0.7504725897920604,0.9775545618563123,1.0,17/78,18.23%,DGKG;DGKQ;DGKA;PLD2;PNPLA6;DGKZ;LPIN1;LYPLA1;PLA2G4E;CHKA;PEMT;GPAT3;GPAT4;PLA2G4A;DGKI;PLD1;PLPP5
gsea,Homologous recombination,-0.22817269214057356,-0.8563771459364776,0.7027027027027027,0.8038027633517479,1.0,8/39,18.23%,SYCP3;POLD4;RAD51C;BABAM2;RAD51;SSBP1;SEM1;RAD51B
gsea,Insulin secretion,0.21270957016285613,0.8550057589586233,0.7021276595744681,0.9688770062685127,1.0,26/70,20.63%,PCLO;RAPGEF4;KCNMB2;ADCY8;PRKCG;RYR2;PRKCB;CREB3L3;CAMK2D;PRKCA;TRPM4;KCNN3;ADCY1;STX1A;CAMK2A;ADCYAP1R1;KCNMA1;ADCY6;CHRM3;CACNA1C;PLCB4;KCNMB4;ADCY3;ADCY2;ADCY7;ADCY5
gsea,Vitamin digestion and absorption,-0.2965410671394176,-0.8505183308137968,0.6811594202898551,0.8121218345357605,1.0,5/15,32.03%,APOA1;SLC19A2;SLC23A1;CUBN;PLB1
gsea,Glycosaminoglycan biosynthesis,0.23024907957021018,0.8478244446597101,0.716636197440585,0.9661642296927037,1.0,10/46,13.92%,CSGALNACT2;ST3GAL3;EXT2;HS6ST1;HS3ST1;CHPF;HS6ST3;XYLT1;NDST2;B4GALT2
gsea,Fatty acid degradation,-0.2305971385593144,-0.8447479611943638,0.6931330472103004,0.8196893103126761,1.0,18/35,45.69%,CPT1C;ACSL3;ACOX1;CPT2;CPT1A;ACOX3;ADH5;ACAA1A;ECI1;HADH;ECHS1;ECI2;ACSL4;ALDH2;EHHADH;ACSL6;ACAT1;ACADL
gsea,Small cell lung cancer,-0.1946191123659839,-0.8440427150364224,0.7683741648106904,0.8169474943673826,1.0,18/82,21.10%,CYCS;COL4A2;TRAF6;AKT3;FHIT;RXRB;AKT1;LAMC3;LAMB1;BCL2;GADD45A;RELA;CCNE2;LAMA5;MYC;IKBKG;CDKN1B;ITGAV
gsea,NF-kappa B signaling pathway,-0.20064036609152608,-0.8355559082606809,0.7929411764705883,0.8299037683894324,1.0,20/65,32.04%,LYN;BTK;TRAF6;TNFRSF1A;MALT1;ERC1;CSNK2B;CXCL12;BCL2;NFKB2;RELA;IKBKG;LY96;BLNK;TLR4;BCL10;TRADD;TNFSF13B;TICAM1;UBE2I
gsea,Basal transcription factors,-0.22526108619673224,-0.8330401153886443,0.7390396659707724,0.8307747197510974,1.0,12/40,24.52%,TAF13;ERCC3;TAF11;GTF2H5;GTF2B;TAF7L;TAF4B;GTF2E2;TAF8;GTF2F2;TAF10;GTF2A1
gsea,AMPK signaling pathway,0.1898403223799293,0.8297067760120137,0.8031189083820662,0.9903265137425088,1.0,29/107,18.91%,MTOR;INSR;PFKM;ACACA;ULK1;CPT1B;PIK3R2;TSC1;CREB3L3;STRADA;PIK3CD;AKT2;PPP2R5C;PPP2R2C;GYS1;PRKAG1;RPS6KB1;PFKFB2;PRKAA2;MAP3K7;CRTC2;PIK3CA;PFKP;PCK2;SCD3;PPP2R3C;PPP2R2D;PPP2R3D;PRKAG2
gsea,"Parathyroid hormone synthesis, secretion and action",-0.19467742819426495,-0.828728590981051,0.7710583153347732,0.8344381351982092,1.0,26/85,30.19%,NACA;JUND;RHOA;RXRB;ATF2;PLCB1;GNAS;ATF4;BCL2;FOS;MAP2K1;PTHLH;MMP15;MAPK3;EGFR;CREB3;RXRG;ITPR2;EGR1;CREB5;PLCB2;PRKACA;ADCY9;ARHGEF1;CREB3L1;GNA11
gsea,Cocaine addiction,-0.22003552405744187,-0.8278310791482383,0.7308488612836439,0.8318594137896302,1.0,15/43,31.59%,JUN;BDNF;ATF2;GNAS;ATF4;RELA;PPP1R1B;GRIA2;CREB3;SLC18A2;CREB5;PRKACA;CDK5R1;CREB3L1;GNAI1
gsea,Long-term depression,-0.21047138916205504,-0.8231805246406501,0.7356076759061834,0.8362061376965483,1.0,12/57,19.98%,HRAS;KRAS;LYN;PPP2R1A;GRM1;PPP2CA;PLCB1;GNAS;PRKG1;MAP2K1;GRIA2;MAPK3
gsea,Notch signaling pathway,-0.2114806308503263,-0.8204782153430171,0.7708333333333334,0.8370930983156029,1.0,15/46,32.10%,HES1;MAML3;SNW1;DVL1;JAG1;MAML2;CTBP2;PSENEN;LFNG;NUMB;HES5;CIR1;DLL3;APH1A;NOTCH1
gsea,Wnt signaling pathway,-0.17935903074532158,-0.818474412876807,0.847457627118644,0.8362964155924181,1.0,37/128,28.27%,GSK3B;JUN;PPP3R1;PPP3CA;RAC1;CCND3;RHOA;GPC4;DVL1;PLCB1;FBXW11;NOTUM;VANGL2;CSNK2B;FZD1;SIAH1B;RUVBL1;NKD1;CTBP2;FZD9;CTNNBIP1;CAMK2B;FRAT1;MYC;FZD2;TBL1XR1;FZD3;RAC3;NFATC1;ROR1;WNT2B;PLCB2;PRKACA;SIAH1A;AXIN2;CCND2;SERPINF1
gsea,Galactose metabolism,0.24675176447820174,0.8118261201589154,0.7434456928838952,1.0,1.0,7/25,14.88%,PFKM;GALE;HKDC1;PGM2;B4GALT2;GANC;PFKP
gsea,Non-small cell lung cancer,0.2016147732362506,0.8101282130909154,0.8076190476190476,0.9947130949920782,1.0,15/63,14.52%,PRKCG;PIK3R2;GRB2;PRKCB;RASSF5;PRKCA;PIK3CD;AKT2;JAK3;POLK;RXRA;ALK;STAT5B;PIK3CA;E2F2
gsea,Longevity regulating pathway,0.18819616818336468,0.8088854469339005,0.8395303326810176,0.9783779849519301,1.0,14/92,10.74%,RB1CC1;MTOR;EHMT1;INSR;ADCY8;ULK1;PIK3R2;TSC1;CREB3L3;PIK3CD;AKT2;PRKAG1;RPS6KB1;ADCY1
gsea,Dilated cardiomyopathy (DCM),-0.1927943439732404,-0.8087212975229815,0.8261758691206544,0.849398730539395,1.0,24/74,32.10%,ACTB;ACTG1;TGFB1;ITGA8;TPM1;GNAS;CACNB3;CACNA1F;SGCB;EMD;ITGAV;ITGB1;ITGA7;ITGA10;ITGA4;PRKACA;MYH7;ADCY9;TPM2;ITGB5;MYH6;ITGA11;AGT;CACNG5
gsea,Hypertrophic cardiomyopathy (HCM),-0.1923830635486418,-0.7986152429925877,0.8472505091649695,0.862564122313795,1.0,21/69,32.10%,ACTB;ACTG1;TGFB1;ITGA8;TPM1;CACNB3;CACNA1F;SGCB;EMD;ITGAV;ITGB1;ITGA7;ITGA10;ITGA4;MYH7;TPM2;ITGB5;MYH6;ITGA11;AGT;CACNG5
gsea,Cholinergic synapse,-0.18373129113372844,-0.7974543597735451,0.8607594936708861,0.8603167632529795,1.0,27/99,27.74%,HRAS;KRAS;KCNJ3;GNG7;AKT3;KCNJ2;PLCB1;ATF4;CHRNA7;AKT1;BCL2;CACNA1F;FOS;MAP2K1;PIK3CG;CAMK2B;GNG3;MAPK3;CREB3;GNB2;KCNJ14;ITPR2;CREB5;PLCB2;GNG10;PRKACA;ADCY9
gsea,Pantothenate and CoA biosynthesis,-0.2669721443800091,-0.7948100928544319,0.7525987525987526,0.8604938827087669,1.0,10/15,42.48%,AASDHPPT;PANK2;ENPP1;DPYS;DPYD;PPCS;BCAT1;PANK3;ENPP3;COASY
gsea,Propanoate metabolism,-0.23053730718964544,-0.7928195973836883,0.7918367346938775,0.859067693296539,1.0,5/28,14.79%,SUCLG1;MCEE;ECHDC1;LDHB;HIBCH
gsea,Malaria,-0.2368317852304484,-0.7856886760416049,0.7730337078651686,0.8661394312018884,1.0,14/24,38.91%,CD81;TGFB1;THBS3;HBA-A2;IL18;TLR4;HBB-BT;ACKR1;PECAM1;HBB-BS;HBA-A1;CD36;TGFB3;LRP1
gsea,Toll-like receptor signaling pathway,0.1979269917216701,0.7726627086420917,0.8616822429906542,1.0,1.0,13/62,13.68%,MAPK10;STAT1;CHUK;IKBKB;PIK3R2;PIK3CD;AKT2;MAPK14;TIRAP;IFNAR1;TAB1;MAP3K7;PIK3CA
gsea,Ether lipid metabolism,0.21351532450235633,0.7492894112660109,0.8563327032136105,1.0,1.0,9/34,18.23%,ENPP6;PLD2;TMEM86B;ENPP2;PLA2G4E;UGT8A;PLA2G4A;PLD1;PAFAH2
gsea,Terpenoid backbone biosynthesis,0.23719977441093856,0.7376973595431365,0.8461538461538461,1.0,1.0,6/20,18.89%,PDSS1;FNTA;ZMPSTE24;RCE1;PDSS2;DHDDS
gsea,Nucleotide excision repair,0.19053708770817132,0.7283184246555807,0.9168207024029574,1.0,1.0,9/43,13.17%,ERCC4;ERCC6;GTF2H1;CUL4A;POLD1;CUL4B;GTF2H4;ERCC2;CDK7
gsea,Glycerolipid metabolism,0.1855110500674348,0.7209716062824347,0.9163346613545816,1.0,1.0,11/48,20.91%,DGKG;DGKQ;DGKA;DGKZ;LPIN1;GPAT3;GPAT4;DGKI;PLPP5;PLPP4;MGLL
gsea,African trypanosomiasis,0.23675645488513702,0.7190098544271375,0.85,1.0,1.0,4/19,9.88%,PRKCG;PRKCB;PRKCA;LAMA4
gsea,Glycosaminoglycan degradation,0.23538237369826076,0.7050577395940998,0.8546845124282982,1.0,1.0,1/17,0.20%,HEXB
gsea,Basal cell carcinoma,-0.17899837761147297,-0.6899549445138721,0.9406175771971497,0.967612055539796,1.0,20/48,41.34%,GSK3B;DVL1;FZD1;GADD45A;FZD9;FZD2;FZD3;WNT2B;DDB2;AXIN2;BAX;GLI3;FZD8;SMO;CTNNB1;GADD45G;WNT5B;PTCH2;TCF7L2;AXIN1
gsea,Butanoate metabolism,-0.21923136403693994,-0.6617897546610714,0.9087301587301587,0.9810764487391653,1.0,3/18,17.79%,BDH1;ALDH5A1;HMGCS1
gsea,Hematopoietic cell lineage,-0.16734144347034563,-0.6523632369987197,0.9703196347031964,0.9811972624178552,1.0,23/50,40.43%,CD24A;CSF1R;CD38;TFRC;IL1R2;ITGAM;CD37;CR2;IL11RA1;ITGA4;IL4;EPO;CD33;IL6RA;CD9;EPOR;CD55;CD36;SIGLECH;IL5RA;H2-DMA;ITGA2;FCER2A
gsea,Cell adhesion molecules (CAMs),0.1556916588429708,0.6430927548320332,0.9818181818181818,1.0,1.0,15/81,15.96%,NFASC;L1CAM;PTPRM;CNTN2;CNTNAP1;CDH4;SDC2;PTPRF;VCAN;NLGN2;CADM3;H2-M5;GLG1;CD274;IGSF11
gsea,ECM-receptor interaction,0.16208695903044715,0.6406690124474727,0.9787234042553191,1.0,1.0,20/65,23.29%,THBS2;SV2A;ITGA3;LAMC2;RELN;LAMA4;CD44;COL6A2;COL1A2;COL6A3;COL6A5;SV2B;LAMA3;DAG1;FN1;TNC;ITGA1;HSPG2;THBS1;COL6A4
gsea,Arginine biosynthesis,-0.21377685337584357,-0.6253301547187282,0.9316770186335404,0.987444750235515,1.0,7/15,40.10%,ACY1;GLUL;NOS3;ARG2;GOT1;GLS;GPT2
gsea,Mucin type O-glycan biosynthesis,-0.1846018170290206,-0.5995203665504785,0.9556451612903226,0.9898711859859433,1.0,8/23,34.79%,GALNT17;C1GALT1C1;GALNT2;B4GALT5;GCNT1;GALNT4;GALNT1;ST3GAL2
gsea,Autoimmune thyroid disease,0.17491805131683041,0.48465055001614765,0.9927007299270073,1.0,1.0,15/15,82.52%,TPO;H2-M5;TSHR;CD86;H2-M3;TG;CTLA4;CD80;H2-K1;H2-D1;H2-DMA;IL4;H2-T23;H2-T24;H2-T22
gsea,Tryptophan metabolism,-0.13010875853296613,-0.47342353957760724,1.0,0.9988523453747208,1.0,3/32,15.08%,TDO2;KMO;AFMID
gsea,Retinol metabolism,0.16195446604053582,0.47132817241095554,0.9944852941176471,1.0,1.0,7/19,26.61%,RDH11;DHRS4;CYP2S1;RDH10;CYP2C55;CYP2C65;ALDH1A2
gsea,Tyrosine metabolism,0.15322072203449985,0.46874309367459577,0.996415770609319,0.9989598401873665,1.0,2/20,7.35%,ALDH3B1;TPO
